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Abstract 
One of the biggest challenges in embryonic stem (ES) cell biology is to direct 
ES cell differentiation towards a specific cell type. So far, this has not been achieved 
in any meaningful way. Therefore, the alternative method of selecting desirable cell 
types from a mixed pool of cells at different stages of commitment and 
differentiation remains the best option for obtaining pure populations. Several 
methods have previously been employed for this purpose, including 
immunopurification, selective viability or attachment, use of growth factors 
selectively to amplify desired populations as well as lineage selection based on the 
expression of a gene conferring drug resistance from an endogenous tissue 
restricted promoter. 
Soxi is member of the group B of the Sox family of transcription factors, 
expressed during embryonic development in mammals. It is expressed throughout 
the neural axis from the headfolds stage, and also in the lens. Soxi is upregulated 
during ES cell differentiation into neural precursors, and its misexpression causes an 
EC cell line to differentiate into neurons. Soxi expression during nervous system 
development is associated with proliferating cells of the CNS, expression being lost 
as cells exit mitosis and terminally differentiate. Its expression pattern is more 
restricted than that of most other markers for early neural cells such as nestin, 
making it a good marker gene for the study of neural development both in vivo and 
in vitro from ES cells. 
Here I have used gene targeting to generate a reporter ES cell line (46C) in 
which the Soxi open reading frame is replaced by the gene encoding enhanced 
green fluorescent protein linked to a selectable marker. The use of EGFP enables 
the observation of Soxi expression in live cells. The expression of the reporter 
faithfully recapitulates the normal expression of Soxi in vivo in mice generated from 
the 46C cells. This cell line has been used to analyse the differentiation of ES cells to 
neural fates, in particular to characterise a newly discovered, monoculture 
differentiation system. Soxl-EGFP expression is monitored by flow cytometry, which 
enables quantification of the differentiation process. The effect of proteins and 
inhibitors implicated in neural determination has been monitored quantitatively and 
over time using this system. Acquisition of neural fate occurs rapidly in the absence 
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of any inducers or serum, and without formation of multicellular aggregates. BMP-4 
completely blocks this neural fate specification, similarly to the situation in the frog 
and the chick. Collectively, the results indicate that restriction of ES cell pluripotency 




1.1 Embryonic stem cells 
Mouse embryonic stem cells (ES cells) are cell lines derived from the 
pluripotent compartment of early embryos, the inner cell mass of the blastocyst 
(Evans and Kaufman, 1981; Martin, 1981). A blastocyst is composed of an inner cell 
mass component and a layer of trophectoderm externally surrounding the inner cell 
mass and a cavity, the blastocoel. The inner cell mass further differentiates into the 
hypoblast and the epiblast. The hypoblast will give rise to parietal and visceral 
endoderm, both of which contribute to the formation of the yolk sac; the epiblast 
gives rise to the embryo proper (Hogan et at., 1994). Culture of blastocyst stage 
embryos in vitro under suitable conditions in the presence of serum gives rise to an 
outgrowth which can be dissaggregated and replated, producing several types of 
secondary colonies, including some with a characteristic undifferentiated 
morphology. These colonies can be expanded and produce ES cell lines capable of 
continuous propagation and clonal expansion (Robertson, 1987a). ES cells are 
thought to represent the epiblast component of the inner cell mass (Brook and 
Gardner, 1997). 
The derivation and maintenance of undifferentiated ES cells was originally 
dependent on culture on feeder layers of mitotically inactivated mouse embryonic 
fibroblasts (Evans and Kaufman, 1981; Martin, 1981), or in suitably conditioned 
medium (Smith and Hooper, 1987). In the absence of such factors, ES cells rapidly 
lose their undifferentiated phenotype and undergo extensive and irreversible 
differentiation to mesodermal and endodermal cells, implying that maintenance of 
the undifferentiated phenotype is dependent upon active suppression of 
differentiation by factor(s) made by the feeders (Smith and Hooper, 1987). One 
such factor was identified as the IL-6 family cytokine leukaemia inhibitory factor 
(LIF) (Gearing et al., 1988; Smith et at., 1988; Williams et al., 1988). UF and a 
small group of other related cytokines that act through the gp130 receptor can 
alleviate the requirement for feeders in the propagation of ES cell lines (Nichols et 
al., 1990; Yoshida etal., 1994). The processes downstream of gp130 responsible for 
the maintenance of the undifferentiated phenotype depend on the activation of the 
transcription factor STAT3 (Burdon et a/., 1999; Matsuda et al., 1999; Niwa et al., 
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1998). Maintenance of undifferentiated ES cells is also dependent on precise levels 
of expression of the transcription factor Oct4 (Nichols et al., 1998; Niwa et al., 
2000). Embryos lacking Oct4 form blastocysts lacking any pluripotent cells. Instead, 
the inner cell mass can only give rise to extraembryonic trophoblast (Nichols et al., 
1998). Forced overexpression of Oct4 in ES cells causes differentiation into primitive 
endoderm and mesoderm, while repression of Oct4 expression causes 
trophectoderm differentiation (Niwa et al., 2000). 
Self-renewing ES cells are pluripotent like the inner cell mass cells from 
which they are derived. This capacity is demonstrated in vitro by the differentiation 
into a plethora of different cell types (see below), and in vivo upon re-introduction 
into a blastocyst whereby they contribute to all foetal and adult lineages (including 
the germ cell lineage) plus yolk sac mesoderm, allantois and amnion of chimeras 
(Beddington and Robertson, 1989; Bradley et al., 1984). Therefore, ES cells provide 
a model for the study of cell commitment and differentiation as well as providing a 
means to dissect normal development via introduction of specific mutations into the 
genome. The discovery of primate (Thomson et al., 1995; Thomson and Marshall, 
1998) and subsequently human multipotent cell lines (Reubinoff et al., 2000; 
Shambtott et al., 1998; Thomson et al., 1998) spurred a new interest in ES cell 
biology, the potential use of stem cell derived material in cell replacement therapies 
for diseased or damaged tissue (Smith, 1998; Svendsen and Smith, 1999). Recent 
findings (Reubinoff etal., 2001; Zhang etal., 2001) indicating that such a goal may 
be attainable for Parkinsonian degeneration have further fuelled interest in ES cells 
and their differentiation. 
An exciting prospect for the use of ES cell derived material for cell 
replacement therapy is the use of "customised" ES cell lines to avoid immune 
response of the host to the donor cells. This can be achieved by producing an ES 
cell line by nuclear transfer of host nucleus to an unfertilised egg, culture of the 
resulting embryo to the blastocyst stage and derivation of ES cells, which are 
entirely derived from the host-to-be. Experiments with mice have shown that this 
two-step procedure is feasible (Hochedlinger and Jaenisch, 2002; Kawase et al., 
2000; Munsie etal., 2000; Wakayama etal., 2001). 
1.2 Neural induction 
The vertebrate central nervous system originates from a part of the 
embryonic ectoderm, the neural plate. Primitive ectoderm derived from the epiblast 
during gastrulation gives rise to both the neural plate and the epidermis depending 
on the nature of the signals it receives based on its location. Neuralising signals 
emanate from a region known in vertebrates as the organiser (also called 
Spemann's organiser in frogs, Hensen's node in the chick and the node in the 
mouse) which appears at the onset of gastrulation. Transplantation of the organiser 
to an ectopic location in the ectoderm of a host embryo normally destined to give 
rise to epidermis causes the induction of a secondary axis the neural tissues of 
which are derived from the ectodermal cells of the host, while the transplanted 
donor tissue makes mesodermal structures (notochord and pre-chordal mesoderm) 
(Hogan etal., 1992). 
In the mouse, patterning of anterior nervous system requires another tissue, 
the anterior visceral endoderm (AVE)(Thomas and Beddington, 1996), often called 
the head organiser. The AVE can be distinguished molecularly by the expression of 
several genes (Hex, Limi, goosecoid, Otx2, goosecoid, cerberus-related 1 and 
Hesxl)(Beddington and Robertson, 1999). It also produces Nodal, a TGF3-like 
molecule necessary for the establishment of anteroposterior polarity (Brennan etal., 
2001). AVE is required for patterning the anterior of the embryo together with the 
epiblast as shown by transplantation experiments, but is not sufficient to induce 
ectopic neural tissue (Tam and Steiner, 1999). 
The role of the organiser however is not to directly induce neural tissue, 
since dissociation of naïve frog ectoderm is sufficient to cause neural induction in 
the absence of organiser (Grunz and Tacke, 1989). It is now known that the 
organiser participates in the differentiation between neural and non-neural 
(epidermal) ectoderm by antagonising the action of bone morphogenetic proteins 
(BM Ps) (Wilson and Hemmati-Brivanlou, 1995). 
BMP5 are members of the transforming growth factor beta (TGFP) family of 
secreted factors. During gastrulation in frogs, naïve ectoderm cells express BMP4 
and BMP7. The organiser tissue (dorsal mesoderm) that forms during gastrulation 
expresses secreted proteins capable of binding and inactivating BMP5 (Noggin, 
Chordin and Follistatin) (Hemmati-Brivanlou et al., 1994; Piccolo et al., 1996; 
Zimmerman et al., 1996). The effect of inactivation of BMP signals by antagonists 
produced by the organiser is that naïve ectoderm becomes neural. In the presence 
of BMP signals, when for example naïve ectoderm is explanted and cultured in 
BMPs, ectoderm becomes epidermal. These results, derived mainly from work in the 
frog Xenopus /aevis gave rise to the so-called "default model" for neural induction: 
ectoderm is fated to become neural unless BMP signals change its fate to epidermis 
(Hemmati-Brivanlou and Melton, 1997) (Figure idA). 
A conflicting view of neural development is that neural induction starts 
before gastrulation (and therefore before the organiser is present to antagonise 
BMP activity), and that FGF signalling is required for it (Hongo et al., 1999; Launay 
etal., 1996; Streit etal., 2000; Wilson and Edlund, 2001). This view is strengthened 
by the observation that neural tissues can develop in the mouse in the apparent 
absence of a node (Klingensmith et al., 1999), or even in the absence of two BMP 
antagonists (Noggin and Chordin) (Bachiller et al., 2000). In the chick, BMP 
antagonists are unable to impart neural fate on primitive ectoderm or lateral 
epiblast (Streit et al., 1998; Wilson et al., 2000), indicating that neural induction 
involves some other factor(s), possibly acting in conjunction with BMP antagonists. 
A strong candidate for such a factor is FGF. 
In chick ectodermal explants FGF receptor antagonists can block neural 
induction (Streit et al., 2000; Wilson et al., 2001). This can be rescued by BMP 
antagonists if a low concentration of the FGF antagonist is used, but in the presence 
of high FGF antagonist concentration the block is irreversible by BMP inhibition 
(Wilson et al., 2001). Some evidence indicates that a role of FGF signalling is to 
repress Bmp at the transcriptional level (Wilson et al., 2001), and that FGFs have a 
dual role in neural induction: high concentrations of FGF repress Bmp expression, 
whereas lower levels of FGF can act via an unknown, independent mechanism to 
promote neural identity. 
Wnt signalling is also believed to be important for neural induction, as 
injection of Wnt mRNA into early Xenopus embryos causes formation of ectopic 
neural tissue (Baker et al., 1999). However, at later stages of development Wnt 
signals inhibit neural induction (Baker et al., 1999; Wilson et al., 2001). There is 
evidence (Wilson et al., 2001) that the inability of BMP antagonists and FGF5 to 
promote neural fate in prospective epidermal cells in chick is due to Wnt signalling 
10 
Epidermal 
Neural —dissociate -• 
+BMp inhibitors





FctücIoi iii 	13M Ps 	 1 I)1(1 rnai 
I 
	
Organt/et 	 Neural 
Noggin. ctiordii, Iolhstatin. 
c:4I)c1us. Xnr 
Chick embryos 




Figure 1.1 The default model for neural induction 
A: The fate of Xenopus loevis animal cap explants is determined by the culture 
conditions and the presence of active BMP signalling. B: Schematic indicating the 




present in such tissues. High levels of Wnt may inhibit the BMP-independent FGF 
transduction pathway required for neural differentiation in prospective epidermis, 
while absence of Wnt in prospective neuroectoderm allow FGFs and BMP 
antagonists to neuralise it (Wilson et al., 2001) (Figure 1.113). 
Interestingly, cells from the organiser and organiser derivatives express not 
only BMP antagonists, but also Wnt antagonists and FGFs (Glinka etal., 1998; Pera 
and De Robertis, 2000; Shibata et al., 2000), which is consistent with this model. If 
Wnt antagonism and FGF signalling are required for neural induction, an organiser 
graft will provide those as well as BMP antagonists while inducing an ectopic 
nervous system. Therefore, the alternative model for neural induction states that 
Wnt is initially excluded from the prospective neuroectoderm, permitting FGF5 and 
BMP antagonists to act and induce neural tissue, whereas in prospective epidermis, 
Writ and BMP signals synergise to impart epidermal fate (Wilson and Edlund, 2001). 
A common observation in all of these results, in all vertebrates, is that neural 
induction is negatively regulated by BMP signals. This may be seen as evidence that 
the underlying mechanism is similar. 
1.3 Neural differentiation of ES cells 
As mentioned previously, removal of feeders and LIF causes ES cell 
differentiation. In such differentiating cultures, mesodermal and endodermal 
markers are expressed, albeit in a disorganised and ill-defined manner (Smith, 
2001). However, more organised differentiation can be achieved by several 
methods. A variety of different cell types have been produced from ES cells, often 
with simple modifications in the differentiation protocols (Dani et al., 1997; Guan et 
al., 1999; Wiles and Keller, 1991). 
To date, the best-studied mode of ES cell differentiation is the formation of 
embryoid bodies (EBs) (Doetschman et al., 1985). This method for differentiation of 
stem cells has its origin in the study of embryonal carcinoma (EC) cells (Martin and 
Evans, 1975; Martin et al., 1977) and involves the formation of multicellular cell 
aggregates in suspension culture. Within these aggregates, complex interactions 
between heterologous cell types result in the induction of differentiation of stem 
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cells to derivatives of all three embryonic germ layers (Martin et al., 1977). Plating 
of the embryoid bodies causes further differentiation and outgrowth. 
Such differentiation invariably gives rise to multiple cell types (often of all 
three germ layers) and despite its merits in the study of cell commitment and 
differentiation, has little value in the production of cell types for transplantation-
based cell therapy. More homogenous differentiation can be achieved by addition of 
morphogens, use of selective media and plating on different substrata (Dani et al., 
1997; Guan et al., 1999; Okabe et al., 1996; Rohwedel et al., 1999; Wiles and 
Keller, 1991). Retinoic acid is one such example of a morphogen; it is produced by 
Hensen's node (Hogan et al., 1992) and has been shown to be a strong 
posteriorising agent (Kessel and Gruss, 1991) for the whole embryonic axis, 
including the nervous system (Marshall et al., 1992). 
Retinoic acid gradients arise by the synthesis and breakdown of retinoic acid 
by the enzymes RALDH (retinaldehyde dehydrogenase) and CYP26 respectively. RA 
synthesis is occurring (apart from the node) in the posterior mesoderm and later the 
somites, optic vesicles, the gut and also in the differentiating limbs (Niederreither et 
al., 1997). PA breakdown is responsible for the correct level of PA (and 
consequently patterning) of the hindbrain, the vertebrae and the tailbud, with 
abnormal development of these structures in mice lacking CYP26 (Sakai et al., 
2001). Retinoic acid synthesis is not necessary for neural induction, but RA deficient 
embryos have defects in neural patterning including open neural tube, anterior 
truncations and irregular neural tube folding. At least some of these defects may be 
caused by abnormal FgfJ gene expression in the hindbrain (Niederreither et at., 
1999). Retinoic acid has complex effects on embryoid bodies; depending on the 
time of application, the concentration and the duration of the culture it can induce 
widely varied cell types (Rohwedel et al., 1999). 
13.1 Neural differentiation in embryoid bodies 
The generation of ES cell-derived neural cells, especially neurons (Bain, 
1995; Fraichard et al., 1995; Strubing et al., 1995) is a well-studied example of ES 
cell differentiation. Neural differentiation of ES cells has been achieved by several 
different protocols, some of which are strikingly different. Initial insight was 
provided again by EC cells; P19 EC cells readily differentiate into neurons by simple 
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aggregation and retinoic acid treatment (Jones-Villeneuve et al., 1982; McBurney, 
1993). The first protocols for neural differentiation of ES cells were based on the 
P19 differentiation protocol; embryoid bodies were treated with retinoic acid at 
different time windows and then plated onto laminin (Bain, 1995), gelatin (Strubing 
et al., 1995) or tissue culture plastic (Fraichard et al., 1995). 
Cells with overt neuronal morphology appeared after plating, and were 
found to express neuronal specific genes such as neurofilament light chain (NF-L), 
microtubule associated proteins (MAP) 2 and 5, synaptophysin and others. These 
cells were found to respond to a range of neurotransmitters and depolarising 
currents, confirming that they were indeed excitable neurons. Glial cell types also 
appeared in such differentiated cultures, as judged both by morphology and 
expression of specific glial markers. The majority of glial cells produced were 
astrocytes, but oligodendrocytes have been generated and selectively expanded 
from EB cultures (Liu etal., 2000). 
A variant protocol for neural differentiation of ES cells involved the formation 
of embryoid bodies without retinoic acid treatment, but depended on the 
subsequent culture of the attached EBs in a selective, serum-free medium to 
eliminate non-neural cells. Culture in that medium results in a dramatic decrease in 
cell number, but an enrichment of the culture in nestin (Lendahl et a/., 1990) 
positive neural progenitor cells which can be expanded and induced to differentiate 
into neurons with high efficiency (Okabe et al., 1996). 
The majority of neurons generated following EB differentiation are 
GABAergic, with some glutamatergic and cholinergic neurons also generated (Bain, 
1995; Fraichard et al., 1995; Mujtaba et al., 1999; Okabe et al., 1996; Strubing et 
al., 1995). More recently it has been possible to instruct neural progenitors derived 
from ES cells to differentiate to dopaminergic and serotonergic neurons (Lee et al., 
2000b), present in the ventral midbrain. Dopaminergic neurons are those depleted 
in Parkinson's disease, a disease where ES cell-based replacement therapy may be 
particularly applicable (Deacon et al., 1998; Dunnett et al., 2001; Svendsen and 
Smith, 1999). This was achieved by addition of Sonic hedgehog and FGF-8 in the 
medium in which neural progenitors were being expanded. The rationale for this 
instructive mechanism came from experiments with neural plate explants (Ye et al., 
1998). Sonic hedgehog (Shh) is a protein secreted by the notochord and ventral 
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midline during patterning of the neural tube and the brain and has ventralising 
properties (Yamada et al., 1993). FGF-8 is produced by a ring of cells at the 
isthmus, the midbrain-hindbrain border, and regulates the patterning and polarity of 
the midbrain (Crossley et al., 1996). The fact that the neural precursors generated 
from ES cells can respond to morphogenetic cues suggests that they are (at least to 
some degree) plastic, and some parallels can be drawn between neural 
differentiation of ES cells and neural development in vivo. 
FGF8 is also expressed in the limb apical ectodermal ridge, the primitive 
streak, tail bud, the branchial arches, the facial surface ectoderm and other regions 
known to direct outgrowth and patterning (Crossley and Martin, 1995). Targeted 
disruption of Fgf8 causes failure of cell migration through the primitive streak and 
anterior movement of the AVE, resulting in defects in the patterning of the anterior 
ectoderm. A hypomorphic allele of Fgf8 in homozygous state or combined with a 
null allele causes deletions of midbrain, hindbrain and olfactory bulbs as well as 
small forebrain alongside craniofacial and other non-neural defects (Meyers et al., 
1998). FGFR1 null embryos die early in development showing growth and 
mesodermal patterning defects. FGF receptor 1 (FGFR1) null: wildtype chimeras 
show an important role of FGF signalling in primitive streak crossing, resulting in 
ectopic neural tissue. This indicates a role of FGF5 in the germ layer specification 
through morphogenetic movements at gastrulation (Ciruna etal., 1997). 
1.3.2 Stromal cells 
A distinct system for differentiation of ES cells to dopaminergic neurons has 
been described (Kawasaki et al., 2000). This system differs from the other methods 
for neural differentiation in that the differentiation process happens not in 
aggregates, but on adherent co-cultures of ES cells with bone marrow-derived 
stromal cells (PA-6) in serum-free medium. No retinoic acid is used to induce neural 
fate and no Shh or FGF-8 is added to the cultures to induce dopaminergic neurons. 
This is a good indication of an inductive mechanism for the production of neurons 
from ES cells, although the molecular nature of the inducing signal(s) remains 
elusive. Importantly, although this unknown activity (termed stromal cell-derived 
inducing activity or SDIA) can act weakly through a filter, it does not condition the 
medium and surprisingly, is not destroyed by fixation of the stromal cells. Other cell 
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types (e.g. fibroblasts) that do not normally exhibit SDIA can induce dopaminergic 
neuron generation from ES cells after fixation. This may indicate that the inductive 
signal(s) are negatively affected by the presence of surface and/or secreted proteins 
(e.g. UF) in cell types other than PA-6. SDIA-mediated differentiation is suppressed 
in the presence of serum or BMP4. This raises the possibility that neural 
determination of these cells is due to a specific lack of signals inducing alternative 
differentiation, as postulated by the default model, and that the primary role for the 
stromal cells is to provide attachment to the ES cells. The dopaminergic phenotype 
of the neurons produced on PA-6 could be due to the presence of a factor produced 
by the cells. 
1.3.3 Defined media 
The first indication that ES cell neural determination is under inhibitory 
control and resembles "default" amphibian neural induction came by experiments in 
serum-free medium (Wiles and Johansson, 1999). Using embryoid bodies generated 
in chemically defined serum-free medium, this group showed that unless signals of 
the transforming growth factor superfamily (including BMP5 and Activin) were 
present, some neural markers were expressed. In the presence of Activin A, an 
inducer of mesoderm in the frog, mesodermal as well as neural markers appeared, 
along with a strong induction of the Activin antagonist, Follistatin (Wiles and 
Johansson, 1999). BMP-4 treatment resulted in the loss of neural cell markers, 
similarly to the situation in frog ectodermal explants (Wilson and Hemmati-
Brivanlou, 1995). BMP-4 also suppressed differentiation of ES cells in a related 
system (Tropepe et al., 2001). In this case, ES cells were selected in serum-free 
conditions in the presence of LIF, and at a frequency of 0.2% gave rise to nestin-
positive cell aggregates C'neurospheres' which could be then expanded in FGF-2 or 
induced to differentiate into neurons, astrocytes or oligodendrocytes. ES cells 
lacking components of the BMP signalling pathway gave rise to 3.5 fold more 
"neurospheres", suggesting that differentiation in this system is under inhibitory 
control by BMPs (Tropepe et al., 2001). The differentiation was inhibited by blocking 
antibodies to FGF-2, revealing a striking parallel to the situation in the chick, where 
FGF signalling seems to be necessary for neural differentiation of naïve ectodermal 
cells (Streit et al., 2000; Wilson et al., 2000). However, the plating efficiency under 
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the conditions described in that paper is very poor, raising the possibility that the 
effect of FGF-2 is to sustain viability of the initial cell population rather than to 
promote competence for neural induction. 
Taken together, all the above examples of neural differentiation indicate that 
despite being an in vitro system, ES cell differentiation has many similarities to 
normal embryonic development, at least as far as neural induction is concerned. 
1.3.4 Monolayer differentiation 
A novel protocol for the differentiation of ES cells to the neural lineage in 
fully defined, serum-free monolayer culture was recently developed in our 
laboratory (Ying et al., submitted). This protocol involves the plating of ES cells on 
gelatinised plastic in fully defined N2B27 medium (see materials and methods). 
The cells convert efficiently into neural precursors that subsequently 
differentiate to neurons and glia in the absence of serum or added growth factors. 
After dissection of the components of N21527, only transferrin was found essential 
for cell viability, whilst other proteins (i.e. albumin and insulin) assisted with cell 
attachment and survival but are dispensable for differentiation (Ying et al., 
submitted). Under these serum-free conditions initial plating efficiency is lower than 
in more standard serum supplemented media, but subsequent viability is high and 
cell numbers increase exponentially throughout the differentiation process. The 
method is not due to selection or selective amplification of pre-differentiated cells in 
the cultures as for the first 2 days after plating, cells still express Oct-4 and produce 
ES cells monolayers if culture medium is changed to ES cell medium with LIF (Ying 
et at., submitted). Since the differentiation process is happening in adherent 
monolayer, it is possible to observe the morphological changes of the cells as they 
differentiate. 
This system for neural differentiation of ES cells indicates that cellular 
interactions in multicellular aggregates are not necessary for the acquisition of 
neural fate. I have carried out a more detailed analysis of this system which is 
presented in chapter 5. 
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1.3.5 Enrichment strategies 
As seen above, different groups use slightly different protocols in order to 
generate neural cells (Gottlieb and Huettner, 1999), and this often is dictated by the 
cell type desired. Since the available protocols almost invariably gave rise to a mixed 
population of neural and non-neural cells of varying stages of commitment, the 
stage following the initial differentiation often served the purpose of selecting the 
desired cells from the pool. This has been accomplished by a variety of methods. 
The selective viability in a minimal culture medium mentioned before (Okabe et al., 
1996) is the first such example. Others include immunopanning for neural antigens 
to select neural- or glial- restricted progenitors (Mujtaba et al., 1999), a combination 
of growth factor stimulation and differential adhesion to obtain oligodendrocyte 
precursors (Liu et al., 2000), and the use of a selectable marker knock-in to select 
neural precursors (Li et al., 1998). 
This technique of lineage selection depends on the restriction of expression 
of the selected gene, but can yield pure populations of cells in a short time and 
following any differentiation protocol. A first application of it is based on the fact 
that proliferating neural progenitors arise during differentiation, and they express 
the early neural gene Sox2. A selectable marker (l3geo) introduced into the Sox2 
locus enables the purification of Sox2 expressing cells by addition of G418 during 
differentiation. Non-neural and post mitotic neural cells not expressing Sox2 are 
killed by the drug resulting in a homogeneous population of Sox2 positive cells. 
These cells can then be expanded in the presence of mitogens or left to differentiate 
to functional neurons and glia (Figure 1.2) 
An important issue regarding the potential use of ES cell-derived material for 
transplantation in diseased or lesioned central nervous system (CNS) is the 
production of the correct neuronal class and the elimination of persistent ES cells, 
which usually cause teratocarcinomas when transplanted into an animal (Evans and 
Kaufman, 1983). In the case mentioned above, where the Sox2 gene was used to 
drive selection, persistent ES cells could not be eliminated because they too express 
Sox2. A combination of positive (Sox2) and negative selection for an independently 
targeted ES specific gene (Oct4) can give the desired purity (Q-L Ying, J Kawaguchi 














Figure 1.2 The principle of lineage selection as applied to ES cell neural 
differentiation 
Top: gene targeting results in the insertion of a reporter/selectable marker into a 
Sox gene. Bottom: Following ES cell differentiation, cells expressing the 
reporter/selectable marker can be purified by flow cytometry or selective media and 
then induced to differentiate to neurons, astrocytes and oligodendrocytes. Figure 
adapted from Svendsen and Smith, 1999. 
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1.4 Sox genes 
The Sox genes are a family of transcription factors identified by homology to 
the mammalian testis-determining gene, Sry (Gubbay et al., 1990). There are now 
many members of the family found in organisms as diverse as human, rodents, 
amphibian, fly, worm and fish (reviewed in (Pevny and Lovell-Badge, 1997; Prior 
and Walter, 1996; Wegner, 1999). Their defining characteristic is the presence of a 
"Sry box", a high mobility group (HMG)-like DNA binding domain which gives the 
family its name. Sox family HMG boxes have at least 50% sequence identity with 
that of the founding member of the family, mouse Sty (Denny et al., 1992; Pevny 
and Lovell-Badge, 1997). Sox genes are a large family of at least 24 members, and 
can be further categorised into groups according to the homology of their HMG 
boxes. 
Members of the same group have more than 80% homologous HMG boxes, 
and often share homology even outside the HMG domain (Collignon et al., 1996; 
Wegner, 1999). The HMG box of Sox proteins can bind DNA in a sequence specific 
fashion, a function shared only with members of the TCF/LEF family of HMG box-
containing proteins (Laudet et at., 1993). The Sox consensus binding motif is the 
heptamer 5'-(A/T)(AfT)CAA(A/T)G-3' (Harley et al., 1994). Sox family members bind 
to the minor groove of the DNA helix, widening it and inducing a bend of 70-85 0 . 
Because of this property, they can act close to other transcription factors that bind 
the major groove. Therefore, they function as architectural components of 
chromatin apart from their roles as classical transcription factors. They are also 
believed to recruit to the DNA proteins that have no DNA binding activity of their 
own via their C-terminal transactivation domain (Ambrosetti et al., 2000; Kamachi et 
al., 1999; Kamachi et al., 1998; Kuhlbrodt et al., 1998; Nishimoto et at., 1999; 
Nowling etal., 2000). 
Thus, Sox proteins may be able to couple extracellular signals to changes in 
gene expression. Recent evidence indicates that in a similar fashion to the TCF/LEF 
family of HMG box transcription factors, three Xenopus Sox genes, XSox3, XSoxl7a 
and XSoxllfJ can bind ç3-catenin, the intracellular signalling component of the Wnt 
signalling pathway. This indicates that Sox genes could translate extracellular 
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signals (Wnt) to changes in transcription (Zorn et at., 1999). This alleged Sox 
binding to 13-catenin can inhibit its TCF-mediated signalling activity. This property 
may shared with other Sox family members that have regions of LEF homology in 
their C terminal (Kamachi et al., 1998; Zorn et al., 1999). However, these results 
have only been obtained using Xenopus as a model organism and high levels of of 
both Sox and /3-catenin transcripts. No interaction has been shown at physiological 
expression levels, nor in other organisms (or indeed ES cells; Meng Li, unpublished). 
1.4.1 Sox genes in neural development 
Group B Sox family members Soxi, Sox2 and Sox3 have many similarities. 
They share extensive regions of homology even outside the HMG box, can bind the 
same DNA sequences in vitro, all have a single coding exon and share sites of 
expression and roles during development (Collignon et al., 1996; Kamachi et al., 
1998; Wood and Episkopou, 1999). Knockout studies on 56x2 and Soxi have 
provided some evidence for functional redundancy, with effects on homozygous null 
animals seen where each gene is expressed uniquely (either temporally or spatially), 
i.e. the epiblast at the time of implantation for Sox2 and the lens during fibre cell 
elongation in Soxi (Nishiguchi et al., 1998; Pevny et at., 1998). Their expression is 
largely overlapping at and after the neural folds stage in mouse nervous system 
development, with the exception that Soxi is restricted to CNS progenitors whereas 
Sox2 is also expressed in PNS progenitors and also in the gut endoderm. 
Sox2 protein is laid down in the growing oocyte and persists throughout 
preimplantation development (Robin Lovell-Badge, personal communication). Sox3 
starts being expressed slightly later, and its expression is overlapping to that of 
Sox2 at the epiblast component of the pre-gastrulation mouse embryo (Wood and 
Episkopou, 1999). They are both very early markers of neural tissue, with Xenopus 
Sox2 being induced after Chordin expression (Mizuseki et al., 1998), (i.e. a later 
onset of expression than in the mouse, restricted to neural tissue), and remain 
expressed in cells of the developing neural plate and tube (Rex et al., 1997; Rex et 
al., 1994; Wood and Episkopou, 1999). Mouse Sox2 is also expressed by ES and EC 
cells (Yuan et al., 1995). Sox2 (as well as Sox3) expression is also seen in the gut 
(Wood and Episkopou, 1999) and the PNS (Pevny and Lovell-Badge, 1997), but not 
in the neural crest where PNS cells originate. 
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Soxi expression in vivo comes on only at the neural folds stage, and 
thereafter is mostly overlapping to that of Sox2 and Sox3 (Wood and Episkopou, 
1999). As the neural plate folds and fuses dorsally to form the neural tube, 
expression of all three genes is maintained. At the point of floorplate differentiation, 
Soxi transcripts and protein are lost from that region, and so is Sox3 (Pevny et al., 
1998; Wood and Episkopou, 1999). After mid-gestation in the mouse, expression of 
the three genes is maintained in the ventricular zone of the developing CNS (Wood 
and Episkopou, 1999). Soxi is shown to be associated with proliferating cells of the 
neural tube, expression being lost concomitantly with terminal differentiation (Pevny 
et al., 1998). Another region of Sox11213 expression is the developing eye. Soxi 
and 2are expressed during lens induction (Kamachi et al., 1998), and later, Soxi is 
responsible for lens fiber elongation (Nishiguchi et al., 1998). Sox2 regulatory 
sequences confer expression of a I3geo transgene to the neurogenic regions of adult 
mouse brain and neural stem cells cultured in vitro, indicating that the expression in 
proliferating cells of the CNS is a property it shares with Soxi (Zappone et al., 
2000). 
Sox2 is known to activate the Fgf-4 gene in combination with Oct-4, and the 
embryonic stem cell coactivator lJtf.t also with Oct-4 (Ambrosetti et al., 1997; 
Nishimoto et al., 1999; Yuan et al., 1995). It appears that both Soxi and Sox2 are 
mainly acting as activators in combination with other transcription factors (Nowling 
et al., 2000; Uchikawa etal., 1999). 
Known targets of Soxl include the crystallin genes for which its function 
during development is critical (Kamachi et al., 1998; Nishiguchi et al., 1998). During 
neurogenesis the roles of Soxi and 2 may be redundant as they can probably 
activate the same genes (Collignon et al., 1996). Function of Sox proteins is often 
dependent on specificity conferred not by the DNA binding domain, but the C 
terminal transactivation domain (Kamachi et al., 1999). Exchange of HMG boxes 
between Sox genes of different groups makes little difference to their specificity 
(Kamachi et al., 1999). 
The pattern of expression of Sox11213 is strongly suggestive of an important 
role during or just after neural induction. Experiments with dominant negative Sox2 
constructs injected in Xenopus embryos revealed a requirement for group B Sox 
transcription factors in neural induction. The first construct comprised of Sox2 
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lacking a DNA binding domain, while in the other the Sox2 DNA binding domain was 
fused to the engrailed repressor. Both constructs suppressed neural induction in 
animal explants and in vivo from the late blastula stage onwards (Kishi et al, 2000). 
As group B Sox family members can bind the same sequences in vitro (Kamachi et 
al., 1999), the repressor construct could potentially work against Sox3 as well as 
Sox2 (no Xenopus Soxl has been described). 
A gain of function in vitro study had previously implicated Soxi in neural 
determination. Since Soxi (unlike Sox4 is not expressed in ES and EC cells, but is 
rapidly upregulated during their neural differentiation, Pevny et al. (1998) 
misexpressed Soxi to see if it can drive pluripotent P19 EC cells to differentiate 
along the neural fate. Soxi overexpression could substitute for the requirement for 
retinoic acid in differentiation, implicating Soxi in fate decisions during neural 
determination (Pevny et al., 1998). 
1.5 Gene targeting 
Gene targeting is the process of introducing a piece of foreign DNA into the 
genome at a precise location via homologous recombination. Homologous 
recombination in mammalian cells was first observed between homologous pieces of 
exogenous DNA (Folger et al., 1982), but it was soon verified that such 
recombination can occur between exogenous DNA and chromosomal loci, albeit at a 
much lower frequency than had previously been described for yeast cells (Bollag et 
al., 1989; Muller, 1999; Smithies etal., 1985). 
The observation that mouse embryonic stem cells can mediate homologous 
recombination (Thomas and Capecchi, 1987), along with their capacity to contribute 
to the germline of chimeras has led to the extensive use of homologous 
recombination to inactivate genes in the mouse genome to study loss of function 
mouse mutants ("knockout mice") (Capecchi, 1989). This technique has helped 
developmental biologists establish roles for several genes and elucidate signalling 
pathways and genetic interactions in mammals (Muller, 1999). 
The parameters that affect the efficiency of gene targeting have been 
reviewed extensively since the first gene targeting experiments were reported 
(Deng and Capecchi, 1992; Muller, 1999). Briefly, these are the extent of homology 
between the targeting vector and the endogenous locus, the chromosomal locus 
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itself, the use of isogenic DNA in the construction of the targeting vector and (for 
sequence replacement vectors) the distribution of homology flanking the selectable 
marker. 
The homologous recombination frequency increases exponentially with the 
length of total homology of the vector to the chromosomal locus (Deng and 
Capecchi, 1992), provided that both of the homology arms are longer than 1Kb 
(Hasty et al., 1991). Isogenic DNA, derived from the same strain of mouse as the 
cells to be targeted gives an increased efficiency of targeting. This is because of 
variations in sequence (mismatches, polymorphic repeats) present in different 
strains that negatively affect the targeting frequency (Deng and Capecchi, 1992; 
Muller, 1999). In mismatch repair deficient ES cells the targeting frequency at the 
retinoblastoma susceptibility locus with isogenic DNA is as efficient as with non-
isogenic DNA (de Wind et al., 1995). 
Another use of gene targeting, often used in combination with gene 
inactivation studies, is to identify sites of expression of the targeted gene by 
introduction of a histological marker. Most commonly used are the Escherichia coil 
LacZ gene encoding J3-galactosidase which enables staining with the chromogenic 
substrate 5-bromo-4-chloro-indolyH3-D-galactoside (X-gal), or an engineered fusion 
with the neomycin resistance gene (l3geo) (Friedrich and Soriano, 1991). This is 
possible whenever the gene targeting results in the introduction of the reporter 
gene under the control of endogenous regulatory and promoter sequences (Le 
Mouellic etal., 1992; Mansour etal., 1990; Mountford etal., 1994). 
More recently, the green fluorescent protein from Aequorea victoria has 
been employed for such studies. The advantage of GFP and its derivatives and 
mutants is that GFP expression can be visualised directly by fluorescent microscopy 
without fixation of the specimen and histological processing. This means that the 
expression of the targeted gene can be monitored in real time during development 
or the course of the experiment (Chalfie etal., 1994). 
1.5.1 The Cre-lox system 
The Cre (causes recombination) protein is a 38-kDa recombinase isolated 
from the bacteriophage P1. It efficiently promotes both intra- and intermolecular 
synapsis and recombination of DNA both in vitro and in vivo at a specific site, called 
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loxP ( locus of crossing over (x), El), and does not require any other protein factors 
(Sternberg and Hamilton, 1981). These properties have been extensively used in 
gene targeting experiments initially for conditional removal of coding regions of 
genes upon expression of Cre (Muller, 1999). Each lox site is 34bp long and consists 
of two 13bp inverted repeats separated by a spacer region (Hoess et al., 1982). 
Although the sequence of the inverted repeats is vital for Cre-mediated 
recombination, certain mutations in the spacer region are tolerated but alter the 
specificity of recombination (Hoess et al., 1986). A pair of lox sites with the same 
mutation in the spacer region can recombine efficiently with each other, but not 
with the wild-type lox sites. Lox511 sites are such an example, containing a point 
mutation in the spacer region rendering them heterospecific to the loxP sites (Hoess 
et al., 1986). 
1.6 Aim of the project 
As described in this chapter, ES cell neural differentiation is a powerful 
system to study neural induction, monitor the parameters that govern lineage 
commitment and produce material for transplantation studies. The major limitations 
of this system are the disorganised mode of differentiation, qualitative interpretation 
of the results and the inability to study differentiation at single cell level. The aim of 
this project was to create a cell line that would enable the quantitative, real-time 
observation of ES cell specification and differentiation and the selection of pure 
populations of proliferative neural progenitors. The strategy employed to achieve 
this was the introduction of a vital reporter/selection cassette into the Soxl locus via 
homologous recombination in ES cells. 
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2 Materials and Methods 
2.1 Materials 
Unless otherwise stated, all chemicals were of analytical, molecular biology 
or tissue culture grade, as appropriate, and supplied by BDH Laboratory Supplies or 
Sigma. Electrophoresis grade agarose was bought from BioWhittacker Molecular 
Applications (Rockland, USA). Restriction and modifying enzymes were from Roche 
Molecular Biochemicals or New England BioLabs and radioisotopes were supplied by 
Amersham Pharmacia Biotech. Synthetic oligonucleotides were synthesised by 
Oswel DNA service (University of Southampton, UK) 
2.1.1 Solutions 
lx TAE 0.04M Tris-acetate, 0.001M EDTA, pH 7.7 
0.5x TBE 	0.045M Tris-borate, 0.001M EDTA 
20x SSC 	3M NaCl, 0.31VI tn-Na Citrate, pH 7.0 
PBS 	S tablets of PBS salts dissolved in 1L of water 
DEPC water 0.1% Diethyl pyrocarbonate in water 
LB broth 	1% (w/v) tryptone (Difco) 
0.5% (w/v) yeast extract (Difco) 
85mM NaCl 
LB agar 	1.5% (w/v) agar (Difco) in LB broth 
GMEM 	lx GMEM (Gibco) 
10%(v/v) foetal calf serum (Globepharm, Surrey) 
0.25% (w/v) sodium bicarbonate (Gibco) 
0.1% MEM non-essential amino acids (Gibco) 
4mM Glutamine (Gibco) 
2mM sodium pyruvate (Gibco) 
0.1mM 2-mercaptoethanol (Sigma) 
human recombinant Leukemia inhibitory factor (made in-house by D. 
Rout by transfection of COS-7 cells with an expression plasmid and 
harvesting of conditioned media) (UF) 100U/ml 
DMEM/F12 	0.5x DMEM 0.5x F12(HAM) (Gibco) 
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30nM Selenium Chloride 
50ig/mi BSA 
N2B27 medium 	0.5x DMEM/F12 
0.5x Neurobasal medium (Gibco) 
0.5x N2 supplement 
0.5x B27 (Gibco) 
Trypsin solution 	0.025% trypsin (Gibco) 
1.3mM EDTA 
0.1% chicken serum (Flow Labs 
in PBS 
Church & Gilbert hybridisation buffer 	0.5M Na 2 HPO4 (pH 7.2) 
70g/L SDS 
1mM EDTA 




0.5mg/mi Proteinase K (Roche) added just before use 
SM buffer 	 0.1M NaCl 
10mM MgSO4 
50mM Tris pH7.5 
0.01 0/o(w/v) gelatine 
Denaturing buffer 	0.5M NaOH 
1.5M NaCl 
Neutralising buffer 	0.5M Tris pH7.5 
1.5M NaCl 
Top Agar 	 log/I Tryptone (Bacto) 
5g/l Yeast extract (Bacto) 
log/i NaCl 
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2.2 Molecular Biology Methods 
General molecular biology methods were as described in (Sambrook et a/., 
1989). Analytical DNA electrophoresis was routinely carried out in TBE buffered 
agarose, whereas preparatory electrophoresis was done in TAE buffer. 
2.2.1 Screening phageX library 
Phage were grown in E. coil LE392 cells. A single colony of bacteria was 
inoculated into 50ml of LB broth containing 10mM MgSO 4 and grown overnight at 
37°C. Cells were pelleted by centrifugation at 3000g at 4°C for 15 minutes and 
resuspended in lOmI of 10mM MgSO4 . This stock of cells could be used for two 
weeks without any significant change in their plating efficiency. 
The library screened was a 129/01a mouse genomic DNA library in A. 2001 
phage, made by Martin Kennedy, Terry Rabbitts and Andrew Smith obtained from 
Dr. Andrew Smith. 
The library was first tested to establish the number of plaque forming units 
per ml of phage solution. Test plating was carried out just like the screen, only with 
serial dilutions of the phage. Before screening, a titration was carried out to 
establish exactly what volume of phage to use for optimal plaque density. This was 
done as for the screen, but several volumes of phage were tested and the one that 
gave a high number of plaques but fewest overlap between them was used to 
screen the library. These procedures were repeated for each fresh phage 
preparation. 
To screen the library, 300jl  of bacteria were mixed with the volume of 
phage established from the titration and incubated at 37° C for 20 minutes. 8m1 of 
warm (49° C), liquid top agar were added to the mix, and immediately poured on 
15cm Petri dishes of dry LB bottom agar. The dishes were swirled to evenly 
distribute the top agar/phage/cells mix, then incubated at 37 ° C overnight. 
The next day plates were chilled at 4° C for 2h, then the plaques were filter-
lifted. For the first lift, membranes (NYTRAN 0.45; Schleicher and Schuell) were 
placed on the plates for 45 seconds. Markings were made on the plate and 
membrane to help with orientation of the filter after hybridisation. Filters were then 
placed on Denaturing buffer for 3 minutes followed by Neutralisation buffer for 2 x 5 
minutes. Each filter was then rinsed in 2x SSC and baked at 120° C for 20 minutes 
between two sheets of 3MM paper. The membranes were then hybridised with the 
appropriate radiolabelled probe (see below). For the second lift, the same procedure 
was followed, except that membranes were left on the plates for 2 minutes. 
Plaques that gave a positive signal after hybridisation and autoradiography 
on both filter lifts were picked using the wide end of a 1000il micropipette tip and 
resuspended in lml of SM buffer containing a drop of chloroform. 
Secondary and tertiary screening were done using the same procedure for 
each positive plaque. 
2.2.2 Cloning and subcloning 
Cloning of DNA fragments involved restriction enzyme digestion, gel 
purification and ligation. Restriction enzyme digestions were performed according to 
the enzyme's manufacturers instructions. Digested DNA was then ran on agarose 
gels (TAE) for resolution of the fragments. DNA was recovered from the gel by 
cutting a piece of the gel containing the desired band and extracting the DNA using 
Quiaquick gel extraction kit (Quiagen) according to the manufacturers instructions. 
The concentration of the recovered DNA was estimated by agarose electrophoresis 
(TBE) and a 3:1 insert:vector molarity ratio was mixed with 1U T4 ligase in lx 
ligation buffer (Roche) and incubated at least 3 hours at 13°C or at 4°C overnight. 
2.2.3 Transformation of bacterial cells 
Competent DH10 bacteria were routinely used for transformations. 
Competent bacteria were prepared in the following way. A single colony from a 
freshly streaked plate was grown in LB broth overnight at 37°C. lml of the culture 
was used to inoculate lOOmI of LB broth and was returned to a shaking incubator 
until it reached an O.D. 550 =0.3-0.6. Cells were harvested by centrifugation for 5 
minutes at 3000g at 4°C. The pellet was resuspended in 5ml of TSB (10% PEG 
3350, 5% DMSO, 10mM MgCI 21 10mM MgSO4 in LB broth). The mixture was 
incubated on ice for 10 minutes, after which 10% glycerol was added, it was 
aliquoted and snap frozen in liquid nitrogen and stored at -70°C. For transformation, 
DNA was mixed with water to a total of 80j.il. 5j.tl of 5x KCM buffer (0.5M KCI, 0.15M 
CaC1 21 0.25M MgCl 2) was added and the mix was chilled on ice. 10011 of competent 
cells were thawed on ice and added to the DNA mix. That was incubated on ice for 
20 minutes and then at room temperature for a further 10 minutes. 800.il of LB 
broth were added to the cells and they were transferred to a shaking incubator at 
37°C for 40-60 minutes before being plated on LB agar containing suitable selection. 
Recombinant bacterial colonies were screened for the presence of inserts by plasmid 
preparation and restriction enzyme digestion. 
2.2.4 Nucleic Acid Isolation 
2.2.4.1 Plasmid isolation 
Plasmid purification was done from overnight cultures of single bacterial 
colonies in LB broth using Quiagen's minispin kit or maxiprep kit for small and large 
scale preparations respectively, according to the manufacturer's instructions. 
2.2.4.2 Genomic DNA isolation 
ES cells 
ES cells grown for genomic DNA isolation were grown to overconfluence in 24-
well plates or 25m1 flasks. They were rinsed in PBS twice and lysed overnight at 
37°C in lysis buffer. The lysate was transferred to an eppendorf and an equal 
volume of isopropanol was added. The tube was inverted several times until a DNA 
precipitate was visible. DNA was pelleted by centrifugation at 13,000rpm in a 
benchtop centrifuge for 10 minutes, washed in 70% ethanol and resuspended in a 
suitable volume of sterile water. The concentration of DNA was established by 
spectrophotometric analysis at 260nm. 
a) Tails 
Tail tips (0.5-0.7 cm) from newly weaned animals were digested overnight in 
lysis buffer in a 55°C shaking waterbath, and then boiled for 10 minutes. They were 
then centrifuged, and the supernatant was removed and mixed with an equal 
volume of phenol (liquefied, washed with Tris buffer, Fisher Scientific, UK). The 
tubes were then centrifuged for 5 minutes (13,000rpm) and the top aqueous phase 
containing the DNA was removed. An equal volume of a 1:1 mix of 
phenol: chloroform was added to that, the tube mixed and centrifuged for 5 
minutes. The aqueous phase was removed and mixed with an equal volume of 
chloroform and centrifuged. The aqueous phase was again removed and DNA was 
precipitated by addition of 1/10 volume of 10M Na acetate and 2 volumes cold 
ethanol. The tubes were centrifuged for 10 minutes, the DNA pellet washed with 
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70% ethanol, dried and resuspended in 500J TE buffer (1mM Tris-CI, pH7.5; 1mM 
EDTA, pH8). 
22.4.3 RNA isolation 
Total RNA was isolated from cells using Rneasy minikit (Quiagen) according 
to the manufacturers instructions. 
2.2.4.4 Isolation of phage DNA 
1010 plating cells were infected with a single plaque in lOmI LB broth and 
incubated overnight at 37°C. This culture was used as a phage stock for isolating 
DNA. 2ml of cell stock were mixed with imI of phage stock and 200 ml LB broth 
containing 10mM MgSO 4 and were incubated overnight with vigorous shaking at 
37°C. The next day, the culture was checked for lysis and imI of chloroform was 
added for 10 minutes to help complete the lysis. Bacterial debris were pelleted at 
3000g for 10 minutes at room temperature. Bacterial nucleic acids present in the 
supernatant were digested with RNase A and DNase I (lOpg/ml each final 
concentration) at 37°C for 1 hour. An equal volume of 20% (w/v) PEG6000, 2M 
NaCl was added and the mixture incubated on ice for 1 hour. Phage particles were 
pelleted by centrifugation at 12000g for 30 minutes at 4°C. The pellet was drained 
and resuspended in lOmi SM buffer and extracted with chloroform twice. DNA was 
extracted by adding 0.5ml 0.5M EDTA (pH8), imI 5M NaCl and mixing with TE 
buffered phenol followed by centrifugation for 10 minutes. Phenol extraction was 
repeated and the aqueous phase was extracted with chloroform. DNA was 
precipitated with 2 volumes of ethanol, washed in 70% ethanol and air-dried before 
resuspending in TE. 
2.2.5 Southern blotting 
10tg of genomic DNA were digested with 80U of restriction enzyme for 3 
hours in the appropriate buffer and temperature, and then another 40U were added 
for another 1-2 hours. The digested DNA was ran on a 0.8%-1.2% agarose gel 
(TAE) overnight. The next morning, the gel was photographed under short wave UV 
light to nick the DNA, and then placed in denaturing buffer for 20 minutes with light 
agitation. The buffer was replaced and incubation repeated, and then the gel was 
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soaked in neutralising buffer for 2x 20 minutes. Then the gel was blotted onto a 
nylon membrane in 20x SSC overnight. Following transfer, the membrane was 
washed in 2x SSC and then baked at 120°C for 20 minutes. The membrane was 
then hybridised with the appropriate radiolabelled probe 
2.2.6 Radiolabelling of DNA 
DNA was labelled with HighPrime labelling mix following the manufacturers 
instructions. Briefly, 20-40 ng of linear, denatured DNA template were incubated 
with HighPrime (containing buffer, nucleotides, random hexamers and polymerase) 
and 40jCi 32 P-dCTP for 20-40 minutes at 37°C. Unincorporated nucleotides were 
removed by passing the reaction mixture through a ProbeQuant G50 spin column 
(Amersham Pharmacia Biotech). The reaction product was then denatured by 
boiling for 5 minutes, placed on ice for 2-3 minutes and added to the hybridisation 
mixture. Routinely, the probes measured 1.5x10 6 cpm/ml of radioactivity. 
2.2.7 Hybridisation of membranes with radioactive probes 
Membranes were pre-hybridised for 1 hour in 20ml Church & Gilbert buffer 
(Sambrook et al., 1989) at 65°C. After the addition of probe, membranes were 
hybridised overnight at the same temperature. The next day, the hybridisation mix 
was removed and the membranes washed in 2x SSC, 0.1% SDS twice for 20 
minutes followed by two washes in 0.2x SSC 0.1% SDS, before light air-drying. 
They were subsequently wrapped in Saran wrap and exposed to either film (KODAK 
X-omat) in an intensifying screen at -70°C for 1-7 days or in a phosphorimager 
screen for 1 hour-2days. 
2.2.8 Polymerase chain reaction (PCR) 
The PCR was performed in a GeneAmp 9700 thermal cycler from Perkin-
Elmer Applied Biosystems. 
a) Fusion of egfpto Soxi 
lOOj.ig of plasmid pCAGGFP IP was amplified using Pfu polymerase (Promega). The 
reaction also contained, in 50l, 5j.tl of lOx buffer, 7.5tl and 6pJ of primers 
MpsFwd3 and MpsRVLS3 respectively (0.1.ig), 1tl (25.iM) dNTP and 1.11 Taq 
polymerase. The amplification conditions were: 
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94°C 5 minutes 
94°C 30 seconds 
58°C 45 seconds L 30 cycles 
72°C 2 minutes 
72°C 45 seconds 
72°C 10 minutes 
4°C 
c) Fusion of neo to Soxi 
170.ig of plasmid pMGD20neo was amplified using Pfu polymerase (Promega). The 
50p1 reaction also contained 5tl of lOx buffer, 7.5il and 4d respectively of primers 
MPSFWDne01.1 and MPSRVSneo1 (0.1j.ig), lpJ (25MM) dNTP and 1tl Pfu 
polymerase. The amplification conditions were: 
94°C 5 minutes 
94°C 30 seconds 
60°C 45 seconds L 20 cycles 
72°C 45 seconds 
72°C 45 seconds 
72°C 10 minutes 
4°C 
Following PCR amplification, 1d of Taq polymerase was added to the reaction and 
the tube incubated at 72°C for 10 minutes to enable TA cloning of the product. 
2.2.9 DNA sequencing 
Was carried out by D. Kivlichan using the BigDye dideoxy termination 
sequencing kit and a Perkin Elmer ABI-Prism automated DNA sequencer. 
2.3 Cell culture methods 
All cells were maintained at 7.5% CO 2 at 37°C in a humidified incubator 
(Heraeus, B5060 EC/CO2). All manipulations were undertaken in a laminar flow 
sterile hood (ICN). To avoid bacterial or fungal contamination of the cultures, all 
objects and surfaces were wiped with 70% industrial methylated spirits (IMS) 
before commencing work. Tissue culture grade plastics were supplied by Iwaki and 
Nunc. 
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2.3.1 Routine culture of ES cells 
ES cells were cultured on 0.1% gelatine-coated plastic in GMEM 
supplemented with human recombinant leukemia inhibitory factor (UF) (Smith et 
al., 1988; Williams et al., 1988) as described previously (Smith, 1992). LIF was 
prepared by D. Rout by transfecting COS-7 cells with a human LIF expression 
plasmid and harvesting the supernatant. The latter was tested on ES cells by 
limiting dilution, and the smallest amount capable of maintaining self-renewing 
colonies was designated as one unit per ml . Routinely, 100 units of LIF per ml were 
used on the cultures. 
To passage the cells, the medium was removed and the cells rinsed twice 
with PBS. Trypsin solution was added to just cover the cells and the flask was 
incubated at 37°C for 2-3 minutes. The trypsin activity was quenched by addition of 
lOmI of medium, and cells were pipetted into a single cell suspension. The cell 
suspension was then centrifuged (200g, 3mm.) and the cell pellet resuspended in 
10 ml of warm medium. An aliquot of the cells was seeded into a new flask 
containing pre-warmed medium. Routinely, cells were passaged at a 1:5 —1:10 split 
every 2-3 days. 
2.3.2 Freezing and thawing cells 
Cells in flasks were trypsinised to a single cell suspension and centrifuged at 
200g for 3 minutes. The cell pellet was resuspended in imI of freezing mix (medium 
containing 10% dimethyl sulfoxide, AnalaR, BDH) and transferred into a cryotube 
(Nunc). The latter was placed in -80°C overnight and then was transferred to a 
liquid nitrogen cell bank (XCL110, Minnesota Valley Engineering Cryogenics). 
To freeze cells in plates, the medium was removed and freezing mix was 
added just to cover the cells. The plate was then transferred to a polystyrene box 
and stored at -80°C (Ure etal., 1992). 
To thaw cells frozen in vials, the vial was removed from the liquid nitrogen 
bank and thawed in a 37°C waterbath. The contents were transferred into a 30ml 
Universal tube containing 10 ml of pre-warmed medium and centrifuged. The cell 
pellet was gently resuspended in 10 ml of medium and seeded into a 25cm 3 flask. 
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To thaw cells frozen in plates, imi of pre-warmed medium was added into 
each well. The plate was then held between hands until thawed. Two-thirds of the 
medium were carefully aspirated and replaced with fresh medium (Ure et al., 1992). 
2.3.3 Culture of COS-7 and 1OT1/2 cells 
These cells were grown on tissue culture plastic in medium without LIF. 
Passaging, freezing and thawing were as described for ES cells. 
2.3.4 Differentiation of ES cells 
Neural differentiation of ES cells was performed in 6cm tissue culture dishes 
(Nunc) or 6-well plates (Iwaki) coated with 0.1% gelatin. Routinely, 2x10 5 cells 
were plated onto each plate in N21327 medium. Medium was changed every two 
days. To quantify the differentiation, cells were dissociated using 0.5 ml of trypsin 
solution, then trypsin was quenched with 0.5m1 of PBS containing 10%  (v:v) fetal 
calf serum. The number of cells was counted, and then the cells were analysed in a 
flow cytometer. When exogenous effectors were used during the differentiation, 
these were added from the time of plating and changed with the medium every two 
days. Effectors added were: recombinant human BMP-4, recombinant mouse 
Chordin and recombinant mouse Noggin/Fc chimera (R&D Systems, reconstituted in 
PBS+1%BSA and used in dilutions 1:1000-1:500), SU5402 (Calbiochem, 
reconstituted in DMSO and used diluted 1:5000 or less), PD98059 (New England 
Biolabs and Promega, diluted in DMSO and used at 1:10000). 
For embryoid body differentiation, cells were plated onto bacterial grade 
Petri dishes in GMEM and allowed to form embryoid bodies. Medium was changed 
every two days. On day 4, 10 6 M all-trans retinoic acid was added and the embryoid 
bodies cultured for a further 4 days in GMEM + retinoic acid. On day 8, embryoid 
bodies were washed with PBS, trypsinised with 4x trypsin for 5 minutes and 
dissociated into single cells before plating or FACS analysis. 
2.4 Introduction of DNA in cells 
2.4.1 Lipofection of COS-7 and 10T1/2 cells 
2x10 5 cells were plated on each well of a 6-well plate the day before the 
transfection. The next day, 95j.il of serum free GMEM (prepared as normal but 
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without serum) were mixed with 5tl of FuGene transfection reagent (Roche)and left 
at room temperature for 5 minutes. After that time, the mix was added onto a drop 
of 4ig of DNA and left at room temperature for 15 minutes. It was then added to 
the cells which were returned to the incubator and left overnight. Cells were 
photographed the next day. 
2.4.2 Electroporation of ES cells 
Confluent flasks of E14Tg2a ES cells (passage 15) were trypsinised and iü 
cells pelleted and resuspended in 0.7m1 of PBS. 150tg of Sail linearised targeting 
vector DNA resuspended in Odmi of PBS were added to the cells, and the cell-DNA 
mix was transferred to a sterile electroporation cuvette (BioRad 0.4cm gap) for 
electroporation. This was performed in a BioRad Genepulser electroporator at 0.8kV 
and 3F. Immediately after the electroporation, the cells were plated onto 10cm 
gelatinised tissue culture plates at a density of 106  cells per plate. 24 hours after the 
transfection, the medium was changed to selection medium containing 100-200 
pg/ml hygromycin B (Roche). Cells were grown in selection medium for 7-10 days 
until colonies appeared. Single colonies were picked into 24-well plates coated with 
gelatine. Cells were expanded and each clone was split into two plates, one of 
which was frozen as a stock (Ure et al., 1992), while the other one was used for 
DNA extraction and Southern blot analysis. 
For the transient transfection with Cre, cells were grown in a medium flask 
(75cm 3), tryspinised and resuspended in 0.7m1 PBS. They were then mixed with 
50p.g of plasmid pCAGGSCreIP (which contains the gene encoding for Cre 
recombinase under the control of the CAG promoter (Niwa et al., 1991) linked to the 
pac gene conferring puromycin resistance) and electroporated as normal. The cell 
suspension was then transferred to a fresh medium flask and grown for 2 days 
without any selection, to enable efficient excision of the lox511 flanked cassette and 
loss of the plasmid without it integrating. After two days, the cells were trypsinised, 
counted and 102104  cells were plated on 10cm plates. Ganciclovir was added to the 
plates 2 days later and resistant colonies appeared after 5-7 days. Colonies were 
picked, expanded and screened as for the targeting experiments. 
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2.5 Histological analysis 
2.5.1 Immunocytochemistry 
For immunocytochemistry, cells were rinsed twice in PBS and fixed in 4% 
paraformaldehyde in PBS for 20 minutes at room temperature. They were rinsed in 
PBST (PBS with 1% Tween20) twice for 5 minutes to permeabilise the cell 
membrane, and then incubated in PBST with 3% serum and 10%  bovine serum 
albumin (BSA) (blocking solution) to prevent non-specific binding of the antibody. 
They were rinsed twice in PBST again, and incubated in the primary antibody at the 
appropriate dilution in blocking solution either at room temperature for 2 hours or 
overnight at 4°C. After that incubation, cells were rinsed 3 times with PBST and 
incubated for 2-3 hours with the secondary antibody in blocking solution in the dark. 
After that time, the secondary antibody was removed and the cells washed 3 times 
with PBS before observing under a microscope for staining. 
2.5.2 Image acquisition and manipulation 
Images were captured via a Zeiss Axiovert inverted microscope (or a Nikon 
SMZ-U dissection microscope for whole embryos) using a Hamamatsu Orka colour 
camera and Improvision Openlab 2.2.5 software on a Macintosh G3 computer. 
Binning was used for weak fluorescent samples and pseudocolour was applied with 
Photoshop software. Contrast and brightness enhancement of acquired images was 
also performed with Photoshop to enhance weak fluorescence of some images and 
improve the contrast. 
2.5.3 Cryosections 
For cryostat sections of animal tissue, dissections were carried out in PBS 
and then the embryo or tissue was cryopreserved in PBS containing 30% sucrose 
overnight before being embedded in O.C.T. compound (BDH) and frozen on a bed 
of dry ice. For sectioning, the frozen block was equilibrated to the appropriate 
temperature (generally about -18°C) in the cryostat chamber. Frozen sections were 
taken at 20j.im using an AS620 Cryotome (Anglia Scientific Instruments), thaw 




Mice were housed and bred within the University of Edinburgh, according to 
the Animals (Scientific Procedures) Act (UK)1986. They were maintained on a cycle 
of 12 hours dark: 12 hours light with the midpoint of the dark cycle at lam. Litters 
from natural matings were left with parents until 3 weeks of age when they were 
weaned by separating the offspring from the parents. At weaning the animals were 
sexed and tail tips taken for genotyping. At 6 weeks of age the animals could be 
used for mating. Breeding setup, tail biopsies and maintenance of the animal stocks 
was performed by the Biomedical Unit staff in the Centre for Genome Research. 
2.7 Blastocyst injection and chimera production 
Chimeric mice were produced based on protocols previously described 
(Bradley et al., 1984; Robertson, 1987b). All the blastocyst injections and transfers 
were carried out by 3. Nichols or S. White. Briefly, Recombinant ES cell clones were 
injected into C57BL/6 blastocysts. Blastocysts were usually cultured for 3 hours to 
allow the blastocoel to fully expand prior to injection. ES cells were trypsinised, 
washed once and 15-20 cells injected into each blastocyst. Around 10 injected 
blastocysts were transferred to the uterine horn of a pseudopregnant recipient 
mouse. Chimeric pups were identified by coat colour chimerism. E14 ES cells contain 
the A' gene (white bellied agouti) and cchc ch for chinchilla at the albino locus. 
C57BL/6 mice are nonagouti (a) resulting in black colour. Depending on the origin of 
the hair follicle and the hair, the coat of chimeric mice can have black, agouti, 
cream or cream agouti colour. 
2.8 Flow cytometry and sorting 
For flow cytometric analysis, cells were trypsinised and resuspended in PBS 
with 10% FCS (FACS wash). Analysis was performed on a FACSCalibur flow 
cytometer (Becton Dickinson) using CellQuest software. 10,000 events were 
scanned. Cell debris and some dead cells were excluded from the analysis based on 
electronic gates set using forward scatter (size) and side scatter (cell complexity) 
criteria. For timecourse experiments, the settings were determined before the 
experiment commenced using appropriate positive and negative controls, then 
saved and used for all of the time points of the experiment to ensure consistency of 
data acquired. 
For sorting, cell suspensions in FACS wash were kept on ice and appropriate 
numbers of selected populations were sorted either directly into multiwells or into 
tubes containing N21327 medium. To eliminate contamination, after sorting cells 
were grown in the presence of penicillin/streptomycin (Gibco). The sorting was done 
on a Cytomation MoFlo flow cytonieter operated by Steve le Moenic. 
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3 Targeting Soxi in Embryonic Stem Cells 
3.1 Introduction 
In order to investigate further the population of Soxi expressing cells after 
ES cell differentiation and in vivo in developing embryos, we employed the use of 
gene targeting. In this Chapter, the isolation and mapping of the Soxi genomic 
locus, the rationale of the targeting vector, its construction, the gene targeting 
experiment and the analysis of homologous recombinants will be presented. 
As described in chapter 1, the use of a vital marker was deemed necessary 
for the project, so the Aequoria victoria green fluorescent protein was employed as 
a reporter. GFP has been extensively studied and several mutants have been made 
including some with enhanced fluorescence, optimised codon usage for mammalian 
expression and even altered fluorescence wavelength. One such commonly used 
mutant is EGFP which differs from wild-type GFP in two amino acid substitutions at 
positions 64 and 65 (Phe-64 to Leu, Ser-65 to Thr) and in the codon usage which 
has been optimised for mammalian expression. The amino acid substitutions render 
EGFP 35 times more fluorescent than wild-type GFP when excited at 488nm, the 
wavelength most commonly used for excitation in flow cytometry (Cormack et a/., 
1996). This variant of GFP was used for the construction of the targeting vector. 
3.2 Library screen and subcloning 
The aim of the targeting was to introduce the dual reporter/selection 
cassette egfp-IRES-pac into the endogenous Sox-1 locus. This cassette consists of 
the gene encoding for enhanced green fluorescent protein (egfp) linked via a mouse 
encephalomyocarditis virus (EMCV) internal ribosome entry site (IRES) (Mountford 
et al., 1994) to the gene encoding for puromycin N-acetyltransferase (pac). Upon 
transcription, this cassette will create a bicistronic transcript which will be translated 
to make two proteins; eGFP and puromycin N -acetyltra nsfe rase, conferring cell 
autonomous green fluorescence and resistance to the drug puromycin (Niwa et al., 
in preparation). 
The Soxi gene (as well as most Sox genes) has a monoexonic structure 
(Malas et al., 1997; Malas et al., 1996; Pevny and Lovell-Badge, 1997). A phage 
lambda2001 genomic DNA library of 12901a strain mouse was screened with a 
2046bp EcoRI-XhoI fragment of plasm Id pmSox-1 cDNA (7a) (a gift from Dr. L.H. 
Pevny, Sheffield University) containing all of the Sox-1 open reading frame. The 
particular strain was selected because it is isogenic to the ES cells to be targeted, 
i.e. the ES cells are derived from that strain (129/01a). Use of isogenic DNA for a 
targeting vector is established to give better targeting efficiency than use of non-
isogenic DNA (Deng and Capecchi, 1992). Initially, 1.2 x108  plaques were screened 
and 7 gave a positive signal. These were screened again to eliminate mixed clones. 
In this second round, 3 clones hybridised with the Soxi probe, the process was 
repeated for them. Finally, 2 clones (a and b, Figure 3.1A) were found positive and 
phage DNA was isolated for further analysis. 
Initial restriction mapping identified unique restriction endonuclease sites 
and Southern hybridisation was performed with a Soxl cDNA probe to verify the 
identity of the clones. The two clones were then restriction mapped with a variety of 
enzymes and then clone a was subcloned as three XhoI-EcoRI fragments into 
pBluescript II SK+(pBS) (Figure 3.1). The most 5' part of the clone, from the 
polylinker Xholto the first EcoRI site (2 Kb) was cloned into the XhoI-EcoRI sites of 
pBS to make pSoxipri. The 7.1 Kb fragment from that EcoRlsite to the Xholsite in 
the Soxi 3' untranslated region (UTR) was cloned in pBS to make p7.1 5'Soxl, and 
the third fragment (4.5 Kb) of clone a, from the XhoI in the 3' UTR until the last 
EcoRlto make p4.51 3'Soxl (Figure 3.1B). 
These three plasmids were sequenced using the T3 and 17 primers. The end 
of the sequence obtained with the T3 primer on p7.1 5'Soxl (from the XhoI end of 
the insert) was shown by homology search (using BLAST) to be part of the Soxi 
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3.3 Fusion of egfpto Soxi untranslated sequences 
To ensure faithful expression of the eGFP transgene from the endogenous 
Soxi promoter, it was decided to fuse Soxi to egfp. Soxi contains 4 in-frame ATG 
codons at its 5' end that could potentially initiate translation. However, it has been 
proposed (Kamachi et al., 1998) that it is not the first ATG codon that initiates 
translation of SOX1, because it is a poor fit to the Kozak consensus sequence for 
translation initiation (Kozak, 1989), but the second, which is a better match. 
Therefore, it was decided to fuse eGFP to the second in frame ATG of Soxi. To do 
this, PCR primers mpsFwd3 and mpsRLVS3 were designed to amplify the entire egfp 
ORF from pCAGGSeGFP IP which contains the egfp IRES pac cassette under the 
control of the CAG promoter (CMV immediate-early enhancer, chicken 13-actin 
promoter and first intron, 3-globin splice acceptor (Niwa et al., 1991)), using a 5' 
primer that would introduce a fusion to the Soxi leader sequence and first few 
codons (Table 3.1, Figure 3.2). The resulting fusion construct has the 5' UTR (up to 
the KpnI site 37 nucleotides upstream of the first ATG) and possible first three 
codons of Soxi, with the first codon of egfp replacing the second in frame Soxi 
ATG. 
The encoded protein, depending on which ATG actually initiates translation, 
would be either a fusion of three amino acids of Soxi on the N terminus of eGFP or 
eGFP alone. This PCR product was cloned using TA cloning in pCR2.1 TOPO 
(Invitrogen), and sequenced fully using M13 reverse and 17 primers. The sequence 
was verified by homology search to contain no mutations introduced by PCR or 
otherwise. The cloned PCR product was excised as an EcoRI fragment and cloned 
into EcoRI -digested pCAGGSeGFPIP replacing the wild-type egfp present there to 
make pSox1EGFPIPpA. To further verify that the cassette carried no mutations and 
that the fusion did not noticeably affect the level of eGFP fluorescence, this plasmid 
was transiently transfected into COS-7 and 1OT'! 2  cells by lipofection. The cells 
transfected with the fusion plasmid were as bright as those transfected with the 
parental plasmid pCAGGSeGFPIP (Figure 3.3). The expression level however was 
probably higher than it would be in the targeted locus, because of multiple copies of 
the vector and the presence of a strong promoter. 
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Figure 3.2 PCR fusion strategy 
A Strategy for introducing the 5' fusion to egfp by PCR (primers indicated) B The 
fusion product shown schematically in pCR2.1 TOPO (17 and M13 reverse primer 
sites used for sequencing are indicated) C The fusion product in the final plasmid 
pSox1EGFPIPpA 
3.4 Vector construction 
Plasmids p7.1 5'Soxl and p4.51 3'Soxl were further mapped by restriction 
enzyme digestion (Figure 3.113) to identify useful restriction endonuclease 
recognition sites for the assembly of the targeting vector. It has been shown (Deng 
and Capecchi, 1992; Thomas and Capecchi, 1987) that the targeting efficiency is 
exponentially dependent on the extent of homology to the target, so the targeting 
vector was designed to incorporate the longest practical homology to the Soxi 
genomic locus, given the restriction map information and genomic clones available. 
We aimed to replace the entire Soxi ORF with the reporter/selection cassette eGFP 
IRES pac, so that it would be under the transcriptional control of the endogenous 
Soxi regulatory sequences, with minimum alteration to the non coding sequences. 
Therefore, the use of a sequence replacement vector was deemed necessary 
(Thomas and Capecchi, 1987). Homologous integration of the targeting vector 
results in the replacement of 1587bp of Soxi sequences (all of the ORF and 412 bp 
M. 
Figure 3.3 Transient transfections 
a-b: 10T1/2 cells transfected with plasmids pCAGegfpIP and pCAGSoxegfplP 
respectively. Scale bar =50tm. c-d: COS-7 cells transfected with the egfp and Sox-
egfp constructs respectively. Scale bar =100tm. 
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of the 3' UTR) with the reporter/selection cassette. The length of total homology 
was decided to be about 8 Kb. This length of homology is considered sufficient for a 
targeting vector to target efficiently (Deng and Capecchi, 1992), and is short 
enough in order to be cloned easily and to be introduced efficiently into ES cells. 
The restriction sites that were suitable for the vector construction and screening 
strategy dictated that the 5' homology arm would be a 5.5 Kb EcoRI-Kpnlfragment 
from p7.1 5'Soxl, and the 3' homology arm would be a 2.5 Kb XhoI-Spelfragment 
from p4.51 3'Soxl. The vector in which the construct was put together was 
pUC19polymps (pUC19 with a modified polylinker). To modify the pUC19 polylinker, 
a set of two complementary oligonucleotides (Link1.1 and Linkl.2) that contained 
the required restriction endonuclease recognition sites was ordered, annealed and 
cloned into the XbaI-HindIII sites of pUC19 to create pUC19polymps. 
The sequence of Link1.1 and Linkl.2 was such, that it replaced all the 
restriction sites between Xbaland HindIIIon the pUC19 polylinker with XhoI, Spel 
and Sa/l (table 3.1). To construct the targeting vector, the 5' homology (5.5 Kb 
EcoRI-KpnI fragment) was cloned from p7.1 5'Soxl into pUC19polymps to give 
pSoxiKOl. Then, the 3' homology arm (2.5 Kb XhoI-Spelfragment) from p4.51 
3'Soxl was cloned into pSoxiKOl to generate pSox1K02. 
A 873 bp KpnI-EcoRlfragment from pSox1eGFPIPpA containing the fusion product 
(see section 3.3) was three-way cloned with a EcoRI-BamHl fragment from 
pCAGGSeGFPIP containing IRES-pac polyA into the KpnI-BamHI sites of pSox1K02 
to generate pSox1K03. 
The final step in the construction of the vector was to insert a selectable 
cassette for selection in ES cells. To this end, plasmid pCMVHyTk was used as a 
basis. This plasmid encodes for the fusion protein HyTK which results from fusing 
the hyrgomycin resistance gene hph with the HSV Thym/dine Kinase ( TX) gene 
(Lupton etal., 1991). This is under the control of the CMV Immediate Early 
Enhancer (CMV LEE) which gives high expression in ES cells. This plasmid was 
modified in the following way: A Sa/Isite present in the linker between Hy77(and 
the polyadenylation signal was destroyed by digestion, end fill and religation. The 
same technique was used to eliminate a Bg/Ilsite in the same linker. The resulting 
plasmid, pCMVHy-TK.1-Bgl, was digested with Xholand Barn/-hand the fragment 
containing the CMVHy7Kcassette was cloned into the Sall-BamHI sites of 
pSP72polyl to make pCMVinPSP. This was in turn digested with BamHland the 
fragment with the cassette was cloned into the Bg/Ilsite of pBSlox2 to create 
pCMVinlox. In this plasmid, the CMVHyTKcassette is flanked by lox511 sites in front 
to back orientation. A Bamfllfragment containing the lox511 sites and the cassette 
within them was then cloned into pSox1K03 to make pSox1K04, the final targeting 
vector. The orientation of the CM VHyTK cassette was chosen to be the same as that 
of the eGFPIP cassette (Figure 3.4). 
Table 3.1 
The sequence of the oligonucleotides used in the construction of the targeting 
vector. Restriction sites are indicated: XbaI, XhpI, 5pçj Hfr1QZTL KpriL For the 
fusion primers, Soxi sequences are shown in italics. The two in-frame ATGs of Soxi 
are shown in bold. 
Link1.1 5' 	CTAGACTCGAGCTAGCACTAGTGTCGAC 	3' 








AGATGTACAGCATG GTG AGC AAG GGC GAG 3' 
5' AGC CAC CAC CTT CTG ATA GG 3' 
MPSFWDne01.1 5 'CGGTACCGGTGAA CCCGCTAGCCGCCCAGA TG TAG 
AGGATG GGA TCG GCC ATT GAA CA 3' 
MPSRVSne01 5' TGC TTC CGG CTC GTA TGT TG 3' 
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Figure 3.4 Targeting vector construction 
Diagram of the four stages of the construction of the targeting vector pSox1K04. 
M. 
3.5 Screening strategy for homologous recombinants 
To screen for correctly targeted clones, DNA was screened by Southern 
hybridisation with probes flanking the integration site in the Soxi locus. The 5' 
flanking probe was a r'lKb XbaI-EcoRI fragment from plasmid pSoxipri, 
immediately upstream of the 5' homology arm. Wild-type genomic DNA cut with 
Xbal and hybridised with this probe gives a 10Kb band, which is reduced to 9Kb 
upon correct integration of the targeting vector due to the presence of a XbaI site in 
the targeting vector. The 3' flanking probe was a 1.5Kb EcoRI-Bg/I fragment from 
plasmid p4.51 3'Soxl. This gives a 12Kb wild type band on EcoRI digested genomic 
DNA which is reduced to 5Kb upon correct integration (Figure 3.5). 
3.6 Targeting SoxlK04 in ES cells 
The targeting vector was introduced into E14Tg2a ES cells (Hooper et al., 
1987) as described in Chapter 2. Cells were electroporated with plasmid pSox1K04 
linearised with Sail, selected for 6-8 days in 100.tg/ml hygromycin C, colonies 
picked, expanded and genomic DNA was prepared from each clone. 
From the 200 clones picked, 100 were screened with both probes and 3 
showed correct targeting at both ends (clones 14, 46 and 53, Figure 3.8). The 
clones were also screened with an egfp probe on XbaI digested DNA to verify that 
there was only one cassette integrated into the genome. Two out of three clones 
gave a single 9Kb band (Figure 3.8) which indicates that they only contain one copy 
of the targeting vector. Clone 14 contained multiple copies and was excluded from 
any further analysis. The targeting frequency is therefore 3% in this single 
experiment. 
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Strategy for screening for correctly targeted ES cells by Southern blotting 
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Figure 3.6 Screen for correct excision 
Cre- mediated deletion of the CMV-HyTK cassette at the lox511 sites causes 
increase in the size of the EcoRlfragment hybridising to the 3' probe 
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3.7 Excision of selection cassette 
It is known (Al-Shawl etal., 1988; al-Shawl etal., 1991; Braun et al., 1990; Ellison 
et al., 2000) that male transgenic mice carrying the TK gene rarely transmit it to 
their offspring. In order therefore to get ES cells able to transmit the Soxl-eGFP 
reporter construct through the germline, the selection cassette CMVHyTK was 
removed from correctly targeted clones. 
This was achieved by Cre- mediated site specific recombination at the lox511 sites 
flanking the CM VHyTK cassette. Clones 46 and 53 were transiently transfected with 
plasmid pCAGGSCreIP in which Cre recombinase is under the transcriptional control 
of the CAG promoter (CMV lEE, chicken 13-actin promoter, 3-globin intron). After 
negative selection with ganciclovir, colonies were picked and screened with the 3' 
probe for excision of the CMVHyTK cassette (Figure 3.6). One correctly excised 
clone was obtained from clone 46 (46C, Figure 3.10). The experiment was later 
repeated and more correctly excised clones obtained (not shown). 
3.8 Second vector 
Very little is known about the level of Soxi expression during ES cell 
differentiation. It has been proposed that, to get detectable fluorescence from eGFP 
in cells, around 10,000 molecules of the eGFP protein need to be present in the 
cytoplasm (Patterson etal., 1997). Furthermore, puromycin resistance depends on a 
high expression of the pac gene, and there is evidence (Borman et al., 1995; 
Martinez-Salas, 1999) that IRES mediated translation is less efficient than cap 
regulated translation. It was therefore conceivable that the levels of Soxi 
expression would not be sufficient to produce high enough levels of protein in order 
to utilise either egfp to visualise, or puromycin resistance to select for, Soxi 
expressing cells. To circumvent this possible problem, a second vector was designed 
and constructed to target Soxi with neo, the gene encoding for the resistance of 
cells to the drug G418. Neo has been widely used as a selectable marker in gene 
targeting, and gives resistance even in cases of low expression (for example, the 
LIFR gene; (Chambers et al., 1997; Li et al., 1995)) (Hanson and Sedivy, 1995). 
This vector was very similar to pSox1K04 in that it utilised the same homology and 
the same selection cassette for selection in ES cells (since Soxi is not expressed in 
4• 
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ES cells). A PCR strategy was also used to fuse the nea coding sequence to the 
Soxi 5'-UTR (see table 3.1 for primer sequences of primers MPSFWDne01.1 and 
MPSRVSne01), and the resulting product was TA cloned in pCR TOP02.1. After 
sequencing to verify that no mutations were introduced by PCR, a KpnI-BamHI 
fragment containing the Soxl-neo fusion was cloned in pSox1K02 to make 
pSox1K03neo. The final step was to clone the BamHlfragment containing the CMV-
HyTK cassette between lox511 sites into pSox1K03neo to generate pSox1K04neo. 
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Screening strategy for correctly targeted ES cells by Southern blotting. 
3.9 Targeting Sox1K04neo in ES cells 
The neo targeting vector pSox1K04neo was introduced in E14TG2a ES cells 
by electroporation and clones were selected for hygromycin resistance as with the 
first vector (Soxi is not expressed in ES cells). Screening was carried out using the 
same probes and restriction digests as with the first vector, only in this case the 
sizes of the bands corresponding to the neo targeted clones were 9Kb for the 5' 
probe and 5Kb for the 3' probe (Figure 3.7). 180 colonies were picked, and of the 
97 that were screened with both probes, two correctly targeted clones were 
identified (clones SIN4 and SIN5)(data not shown). The targeting frequency 
therefore is 2.06% in this experiment. 
52 
3.10 Chimera production and germline transmission 
Targeted ES cells from clones 14, 46 and 53 (containing the /-/yTK cassette) 
and 46C from which the cassette has been excised, were injected into 3.5-day old 
C57BL/6 blastocysts by 3. Nichols. Injected blastocysts were transferred to 
pseudopregnant foster mothers. Chimeras were identified by coat colour chimerism. 
Male chimeras were bred with MF1 females and grey coloured offspring (mixture of 
the 129/01a chinchilla with the MF1 albino colours) were tested for presence of the 
Soxi targeted locus by Southern analysis with the 3' flanking probe and PCR (Figure 
3.9). Germline transmission was only obtained from a chimera that did not carry the 
HyTK cassette (see Table 3.2). The analysis showed that 50% of grey pups 
inherited the targeted allele. Consistent with previous findings (Nishiguchi et al., 
1998), heterozygous mice were phenotypically normal, and both males and females 
were fertile and transmitted the transgene at the expected frequencies. The line 
was maintained by backcrossing heterozygous males to MF1 females. 
Homozygous animals were also generated by intercrossing two heterozygotes. 
These animals looked initially smaller than their wild-type littermates. The Soxi null 
animals had smaller eyes with opaque lenses indicating cataract, and started having 
seizures after about two months of age. These findings correlate well with the 




Figure 3.8 Soxl egfP mice 
Soxi null animals appear smaller because of a hunched posture and have seizures. 
A Soxi null animal (arrow) is shown for comparison next to a heterozygous 
littermate. The Soxi null animal has had a seizure minutes before this picture was 
taken and was still trembling. 
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Table 3.2 
Summary of chimera production and germline transmission 
ES cell clone Blastocysts Pups born Chimeras Germline 
injected (male) chimeras(pups born) 
14 28 10 7 (4) 0 (150) 
46 19 6 5 (4) 0(44) 
53 83 8 6 (6) 0(0) 
46C 16 3 3 (3) 1(9) 
3.11 Summary 
Soxi has been targeted with two targeting vectors, containing different 
reporter/selection cassettes. In the case of the egfp-IRES-pac targeted clones, the 
selectable marker CMV/IyTK used for selection of integration in ES cells has 
successfully been removed from one of the clones (clone 46). The targeting 
efficiency was similar for the two vectors (2-3%) which was anticipated as both 
vectors had identical sequence homology to the Soxi locus. The previous targeting 
of the Soxi locus reported (Nishiguchi et al., 1998), does not report clearly on the 
targeting frequency, so the results cannot be directly compared, but the homology 
they used was smaller than that shown here. Chimeras were generated from four 
clones targeted with the eGFP vector, one of which gave germllne transmission. 
Both targeting vectors completely remove one copy of Soxi, replacing it with 
selectable markers. Heterozygous animals were generated. These animals are born 
in Mendelian ratios, are viable, apparently healthy and fertile. Animals lacking both 
copies of Soxi phenotypically resembled the previously reported Soxi —null mice 
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Soxi SCRS: 5' GACTTCGAGCCGAGAAGAGG 3' 
Soxi SCRAS: 5' GCTTGCTGATCTCCGAGTTG 3' 
Sox1SCRFP: 5' GGCGGATCTTGAAGTTCACC 3' 
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Figure 3.9 PCR genotyping 
A Diagram of the PCR strategy for screening tail genomic DNA. B Sequences of PCR 
primers used for genotyping. C A gel showing the result of one such PCR. 
Homozygous wild type and heterozygous animals shown as +/+ and 
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Figure 3.10 Southern blotting of targeted clones 
Genomic DNA was prepared from ES cells, digested with appropriate restriction 
endonulease, ran on agarose gel, blotted and hybridised with the appropriate probe 
as described in materials and methods and above. A: 3' probe, B: 5' probe, C: 
internal EGFP probe 
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4 SoxI expression during development 
4.1 Introduction 
Targeting the reporter gene egfp into the Soxi locus as described in chapter 
3, put egfp under the transcriptional control of the endogenous Soxi regulatory 
sequences. Therefore, sites of Soxi transcription can be visualised in transgenic 
animals by fluorescence microscopy for EGFP. Soxi expression during mouse 
development has been documented before, using an antibody (Pevny et al., 1998) 
and RNA in situ hybridisation (Wood and Episkopou, 1999). However, both of these 
studies only looked at expression during early development. Here, an investigation 
of sites of Soxi expression during mouse development is carried out, using EGFP to 
visualise it. 
Expression described here is as visualised on animals resulting from 
backcrossing heterozygous founder males (mixed 129/01a and MF1 genetic 
background) to MF1 females. In animals carrying egfp, the expression of the gene is 
entirely dependent on the activity of endogenous Soxi regulatory elements as 
described in chapter 3. Embryos were dissected at embryonic days (E) 7, 8, 9, 10, 
11, 12, 14, 16 and 18 and observed whole-mount for EGFP fluorescence. Embryos 
older than E12 as well as adult animals were also cryosectioned and sections 
examined for fluorescence. Adult animals were transcardially perfused with 4% 
paraformaldehyde before embedding to reduce autofi uorescence. 
4.2 Expression before E9 
Since Soxi expression has never been documented before E7, the earliest 
timepoint examined for Sox-EGFP expression was E7. However, no EGFP 
fluorescence was seen at that time point, despite prolonged exposures under UV 
with a digital camera. Fluorescence first becomes visible at around 8.25-8.5 days 
post coitum (dpc, Figure 4. 1), at the early somites stage. Previous studies (Pevny et 
al., 1998; Wood and Episkopou, 1999) put the onset of Soxi expression slightly 
earlier (E7.5 and E8 respectively) when examined using an antibody or by RNA in 
situ hybridisation. This discrepancy is probably due to the time it takes for EGFP to 
fold properly to fluoresce, and/or the time needed for enough molecules of it to 
accumulate in the cytoplasm to give appreciable fluorescence (Patterson et at., 
1997). 
Fluorescence initially appears at the middle part of the neural plate, contrary 
to the previous reports describing expression throughout the neural plate. This may 
be because the tissue is thicker there. By late day 8 Soxi can be seen on all of 
the neural plate, being slightly more prominent at the middle of it where it begins to 
fold (Figure 4.1). This correlates well with the previous studies on Soxi expression 
(Pevny et at., 1998; Wood and Episkopou, 1999), which report uniform expression 
of Soxi throughout the neural plate. 
Soxi has been previously associated with proliferating cells of the neural tube, 
being downregulated as cells exit mitosis and terminally differentiate (Pevny et al., 
1998). By E9, neural induction has finished and the neural plate begins to fold and 
form the neural tube (Ybot-Gonzalez et al., 2002). The neural folds/tube at this 
stage is composed mainly of proliferating precursors. 
Under the influence of Sonic hedgehog (Shh) signals derived from the 
underlying notochord, cells at the ventral part of the neural tube (the region closest 
to the notochord) begin to differentiate into floorplate and upregulate Shh. Shh 
signals induce and repress different classes of homeodomain transcription factors at 
different concentrations. These transcription factors can function in a cell-
autonomous manner to repress each other, thus establishing distinct domains of 
expression along the D-V axis of the neural tube (Briscoe et al., 2000). These 
domains will later give rise to distinct classes of neurons, implicating Shh signalling 
in the patterning of the neural tube. Soxl-GFP appears weaker at the ventral 
midline of the neural tube at the later timepoints, suggesting exclusion of 
expression from the floorplate. 
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Figure 4.1 SoxP fP expression at E85 
a: day 8.5 heterozygous embryo showing expression of the egfptransgene at the 
middle of the neural plate (anterior is top left). Sectioning would have been more 
informative on whether this localisation is due to tissue thickness or reflects genuine 
differences in expression b,c: Dorsal and lateral view respectively, of embryos at 
late E8.5. Fluorescence is seen throughout the neural plate/tube. Note that 
expression is excluded from the somites (arrowheads in c) (A: anterior, V: ventral). 
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4.3 Expression between E9-E13 
After neural tube closure, non-neural ectoderm at the dorsal side of the neural 
tube expresses Bmp genes. BMPs produced by the ectoderm diffuse through the 
intervening mesenchyme and influence the dorsal part of the neural tube, causing 
the dorsal-most cells to form the roofplate (Lee et al., 2000a). The roofplate cells 
start producing BMP signals to pattern the dorsal third of the neural tube (Timmer 
et a/., 2002). These opposing gradients of Shh and BMPs pattern the entire neural 
tube along its dorso-ventral axis. 
Although no experiment was done to specifically address this point, Soxi-
EGFP levels seemed to become weaker at the floorplate and roofplate of the neural 
tube (Figure 4.2 c,d). Cells in these regions are among the first to stop dividing in 
the developing nervous system concomitantly with the acquisition of their roles as 
signalling centres for neural tube patterning. 
After mid-gestation, Soxi expression remains strong throughout the neuraxis, 
with the exception of the roofplate and floorplate (Figure 4.2). During these stages, 
patterning of the neural tube is established and distinct classes of neurons start to 
differentiate and migrate laterally. The proliferative cells become restricted in the 
layers closest to the ventricular area of the tube, and as cells terminally differentiate 
and migrate out, the neural tube thickens. In the Sox1° mice, GFP expression 
progressively becomes restricted to the ventricular layer. In the developing brain, 
expression is strongest at the telencephalic region after E10.5 (Figure 4.2 a,b). 
In the developing eye, Soxi is needed for y-crystallin gene activation 
(Kamachi et al., 1995; Kamachi et al., 1998; Nishiguchi et al., 1998). EGFP 
expression first becomes evident at Eli in the lens. Previous reports put the onset 
of Soxi expression in the lens at E10.5, but the discrepancies can be explained by 
the different methods used for the detection (RNA in situ hybridisation vs. EGFP 
protein fluorescence). Expression of EGFP in the lens is maintained during this 
period (E9-E13). 
In the brain around E12.5, expression is seen in regions of ongoing cell 
proliferation, most notably the cell layers abutting the ventricles and the forebrain 
vesicles which are rapidly expanding to make the cerebral cortex. 
Figure 4.2 Soxi expression between E11.5-E12.5 
a: E10.5 embryo; expression seen throughout the neuraxis. Apparent punctate 
EGFP fluorescence is a photographic artefact b: E11.5 embryo, showing strongest 
expression in the brain. c,d: E12.5 embryos; Soxi expression is excluded from the 
roofplate and floorplate (M), but is seen along the entire length of the CNS (A: 




Figure 4.3 Sections of E12.5 SoxPP heads 
a: Horizontal section through the forebrain. AH: anterior horn of the lateral 
ventricle, MGE: Medial ganglionic eminence. b: Horizontal section at the level of the 
posterior horn (PH) of the lateral ventricle at E12.5. C: E12.5 horizontal section at 
the midbrain. Note expression around the fourth ventricle (IVy). Scale bars, 500tm. 
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4.4 Expression between E13-birth 
After E12, expression becomes restricted to a thin ventricular zone of the 
spinal cord and the developing brain, being strongest in the forebrain and more 
specifically the lateral ventricles. 
During this period, the brain expands by the production of neurons and glia 
and the basic neuronal circuitry is established. Proliferation is restricted to the areas 
adjacent to the ventricles, especially the third and lateral ventricles where the 
telencephalic vesicle expands to produce the cortex. Soxl-GFP expression is seen in 
the forebrain, especially around the lateral ventricles. After sectioning and 
examination of the slides for fluorescence, Soxl-GFP positive cells were only 
detected next to a ventricle. This expression becomes weaker at later stages, and at 
E18.5 is only seen in the subventricular layer of the lateral ventricle. 
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Figure 4.4 Soxi expression at E14.5 
a: Sagittal and b: horizontal sections through E14.5 head. Expression is strongest in 
cells adjacent to the lateral ventricle, in both anterior (AH) and posterior (PH) horn. 
Expression also seen adjacent to the third ventricle (Thy). Scale bar, 500 jim. 
Figure 4.5 	Expression of Soxl-GFP at E15.5 
Frontal view of an E15.5 fetus head. Fluorescence is seen in the lens (*) and in the 
developing cortex (C). 
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Figure 4.6 Coronal section at E12.5 
Expression seen in the lens (*) and in cells around the lateral ventricles (LV). Scale 
bar, 500pm. 
Figure 4.7 The Sox 1 eye at [11.5 
GFP image of the eye of a E11.5 embryo. Expression seen in the lens vesicle 
(arrow) and the presumptive retina (arrowhead). Scale bar, 500 j.im. 
Figure 4.8 Sox1e9fP expression in an adult 
Expression in the adult lateral ventricle subependyma. The section is at a level just 
above the ventricle, showing expression in the subependyma. Scale bar, 500tm. 
4.5 Expression after birth 
After birth, Soxl—GFP is seen at the lateral ventricle where onging 
neurogenesis is occurring (Altman, 1969; Doetsch et a/., 1999; Frisen et al., 1998; 
Johansson et al., 1999a; Johansson et al., 1999b) (Figure 4.8). A limitation of the 
EGFP is that it is often difficult to distinguish between true fluorescence and 
autofluorescence. In the adult brain, strong autofluorescence is associated with 
myelin. Therefore, an apparent expression of Soxi in the cerebellum and the corpus 
caiosum is attributed to autofluorescence since these are regions containing high 
numbers of myelinated axons. 
EGFP expression is also seen along the rostral migratory stream, the route followed 
by migrating neuroblasts generated in the subventricular zone to the olfactory bulb 
(Doetsch et al., 1999). 
4.6 Summary 
Regions of Soxi expression were visualised by fluorescence microscopy for 
the EGFP marker introduced into the Soxi locus. The sites of expression shown here 
correlate well with other studies of Soxi expression carried out by in situ 
hybridisation (Kamachi et al., 1998; Wood and Episkopou, 1999) or 
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5 SoxI as a reporter of ES cell differentiation 
5.1 Introduction 
As mentioned before, the reason for developing the 46C cell line was to 
study ES cell differentiation to the neural lineage and purify cells of that lineage 
from other cell types coming through the differentiation protocol. The technique of 
lineage selection has been used previously in this laboratory for neural 
differentiation, by virtue of a Sox2 reporter cell line (Li et al., 1998). However, the 
expression of Sox2 is broader than that of Soxi (Pevny and Lovell-Badge, 1997; 
Wood and Episkopou, 1999) and it is also expressed in ES cells. 
Therefore, a Soxi reporter cell line utilising EGFP was constructed as 
described in chapter 3. The main advantage of having EGFP as a reporter is that it 
enables observation in live cells and tracking the activity of the endogenous 
promoter over time in the same cell (timelapse imaging). Another advantage of the 
use of a vital label such as EGFP is that it permits the use of flow cytometry to 
accurately monitor levels of expression in a mixed population of cells, to quantify it 
and to sort cell populations based on the marker gene expression. I have used a 
combination of the above techniques to study ES cell differentiation and factors that 
affect it. 
5.2 46C cells express egfp after differentiation 
Embryonic stem cells can differentiate along the neural fate by a variety of 
methods (Bain, 1995; Fraichard et al., 1995; Kawasaki et al., 2000; Tropepe et al., 
2001). It was described in the previous chapter that the expression of the EGFP 
reporter correctly followed the expression pattern described for Soxi in vivo. In 
vitro, during ES cell differentiation, Soxi is expressed by neural progenitors (Li et 
al., 1998). This process begins after addition of retinoic acid during differentiation in 
embryoid bodies (Bain, 1995; Fraichard et al., 1995) on day 4 (3. Aubert, 
unpublished data). 
In order to test the fidelity of the reporter gene expression during in vitro ES 
cell differentiation, 46C cells were subjected to embryoid body differentiation and 
analysed at different timepoints for green fluorescence. No green cells were 
detected in undifferentiated populations of 46C ES cells or in embryoid bodies 
before treatment with retinoic acid, in agreement with RT-PCR data suggesting that 
Soxi is not expressed in these cells (3. Aubert, unpublished). After retinoic acid 
treatment on day 4 of EB differentiation, some of the cells started to activate the 
Soxi locus and consequently fluoresced green (Figure 5.1). By day 8, a significant 
portion of the cells in each embryold body were EGFP positive. 
5.3 	Monolayer differentiation 
ES cell differentiation in vitro to the neural lineage is initiated via poorly 
understood interactions in serum-containing medium (Fraichard et al., 1995; Okabe 
et al., 1996), multicellular aggregates (Tropepe et al., 2001) and/or co-cultures 
(Kawasaki et al., 2000) often in the presence of morphogens (e.g. RA) (see section 
1.3). These protocols are hindered by varying degrees of heterogeneity in terms of 
their efficiency in generating neural cells often caused by the use of non-defined 
media containing as much as 10%  serum (Strubing et al., 1995), the 
uncharacterised interactions between aggregated cells (Tropepe et al., 2001) or the 
use of stromal cells to induce the differentiation (Kawasaki et al., 2000). 
These conditions preclude a systematic dissection of the factors required for 
neural lineage specification of ES cells because of their variability and qualitative 
nature. In most cases it is virtually impossible to assess the effect of an added 
factor on the differentiation efficiency until the experiment has finished and the cells 
fixed and processed immunocytochemically. In other cases, where relatively 
homogeneous populations of cells are obtained by differential viability in a 
chemically defined medium (Lee et al., 2000b), the initial differentiation steps are 
poorly characterised and the selection process amplifies a rare fraction of the 
starting cell population. 
A novel protocol for the differentiation of ES cells to the neural lineage in fully 
defined, serum-free monolayer culture was recently developed in the laboratory 
(Ying etal., submitted) (see section 1.3.4). The entire process can be monitored at 
the level of individual cells. 46C cells were used to analyse the commitment of cells 
during the differentiation process. The first GFP positive cells appeared in the 
cultures 3-4 days after plating and shortly after this the majority of cells expressed 
EGFP. The acquisition of GFP fluorescence happens asynchronously between 
colonies. This indicates that neural commitment is not the result of an enviromental 
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cue, rather a stochastic process. As the cells progressively differentiate into neurons 
and glia, they downregulate Soxi and consequently lose GFP fluorescence. The cells 
are often arranged into rosette-like colonies, in which the majority of cells are 
expressing EGFP (Figure 5.2). 
The growth kinetics of cells undergoing such differentiation were measured 
by cell counts at 9 hours after plating and each day thereafter for 9 days. The 
results indicate that despite an initial reduction in cell numbers by 19% attributed 
to plating efficiency in serum-free conditions, the cell numbers increase 
exponentially during this period of culture (Figure 5.3). The plot of cell numbers 
over time in a logarithmic scale produces points with strong linear regression 
(r2=0.931, P<0.001). 
Since the differentiation process is happening in adherent monolayer, it is possible 
to observe the morphological changes of the cells as they differentiate. This is 
contrasting to EB and to PA-6 differentiation where differentiation happening in cell 
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Figure 5.1 Fluorescence after retinoic acid treatment of 46C embryoid bodies 
46C ES cells were differentiated as embryold bodies for 4 days in medium without 
LIF, and for a further 4 days in medium without LIF supplemented with 10M all-
trans retinoic acid. On day 8, EB5 were trypsinised and analysed by flow cytometry. 












Figure 5.2 Rosette of 46C cells 
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Figure 5.3 	Culture growth during monolayer differentiation 
Plot of cell numbers during monolayer differentiation. Points are averages of two 
experiments performed in triplicate. Regression significant at P<0.001. 
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Figure 5.4 Timelapse study of 46C monolayer differentiation 
Consecutive photomicrographs of the same field were taken at regular 
intervals. Pictures taken in collaboration with Dr. QiLong Ying. ES cells were 
plated at clonal density in ES cell culture medium for 24 hours, to allow 
them to attach. The medium was then changed to N21327 and a selected 
field was observed every 2-4 hours and a picture taken. Under these 
conditions, alternative differentiation is more pronounced, presumably due 
to the presence of traces of serum during the early stages of the 
differentiation process. The flat, large cells apparent in this timelapse 
experiment cannot be responsible for the differentiation, as they do not 
appear in most of the differentiation experiments described here. The 
observation of the cells every 2-4 hours was necessary to avoid killing the 
culture, but presents the limitation that individual cell divisions cannot be 
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The characteristic ES cell morphology is progressively lost, as cells initially 
become flatter and resemble an epithelium, later to be replaced by smaller, bipolar 
cells that are often arranged in a rosette structure and later by neurons and glia 
that downregulate the EGFP reporter (Figure 1.4 for timelapse images of the same 
colony). 
In order to quantify the conversion of ES cells to EGFP positive presumptive 
neural precursors, 46C cells were differentiated in monolayer culture and each day 
analysed by flow cytometry for EGFP expression. Undifferentiated ES cells do not 
show any fluorescence before the differentiation protocol starts, so the marker 
region for GFP+ was set to exclude 99% of the initial ES cell population. 
In the first two days after plating, less than 10% of cells became positive for 
GFP. On day 3, the proportion of live cells that were within the marker region had 
increased to around 42%, and a day later to 75%. During days 5, 6 and 7 the 
proportion of GFP positive cells remains approximately stable around 75-80%, 
before starting to decrease as cells turn off Soxi and terminally differentiate to GFP 
negative neurons and glia (Figure 5.5). By day 10, only around 47% of live cells 
remain EGFP positive. These flow cytometry data are consistent with observations 
made by fluorescence microscopy during the same period. 
Given that the acquisition of EGFP expression is asynchronous between 
colonies and that differentiation to neurons and glia is accompanied by 
downregulation of Soxi in the embryo (Pevny et al., 1998), the number of EGFP 
positive cells at any time point is likely to be an underestimate of the total incidence 
of neural determination. However, not all of the cells in a culture become EGFP 
positive and some remain undifferentiated ES cells, implying that alternative 
differentiation programmes and some self-renewal are at work in these monolayers. 
The different cell types in the culture appear to be proliferating with similar rates, 
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Figure 5.5 Quantitation of monolayer differentiation of 46C cells 
Points are averages of two experiments performed in triplicate. 
5.4 Effect of exogenous factors on the monolayer differentiation 
The impact of candidate regulatory factors on neural determination in 
monolayer differentiation was assessed. Factors to be tested were added at the 
time of plating and replenished every two days when media were changed. The 
proportion of ES cells (for example, by SSEA1 antibody staining) was not measured 
for these experiments. 
5.4.1 LIF 
Leukemia inhibitory factor is a cytokine that acts through the gp130- UF 
receptor heterodimer (Gearing and Bruce, 1992; Stahl et al., 1993). It is routinely 
used on ES cell cultures to maintain the cells in an undifferentiated state in the 
absence of any feeder cells (Smith et al., 1988; Williams et al., 1988). This is 
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achieved by signalling downstream of the LIF receptor/gp130 heterodimer receptor 
and activation of the transcription factor STAT3 (Matsuda et al., 1999; Niwa et al., 
1998). Recently, there has also been a report that LIF is essential for the 
survival/proliferation of a primitive neural precursor derived directly from ES cells in 
vitro or the pluripotent epiblast in vivo (Tropepe et al., 2001). 
Addition of LIF (100 units/ml) during monolayer differentiation suppressed 
the emergence of GFP positive cells (Figure 5.6) and resulted in increased number 
of ES-like colonies. This is in agreement with the normal neuroectoderm formation 
in LIF-receptor knockout embryos (Li et al., 1995), with the established action of LIF 
in promoting self-renewal of undifferentiated ES cells (Smith et al., 1988; Williams 
et al., 1988), and with the inhibitory effect of LIF on stromal cell-induced 
differentiation (Kawasaki et al., 2000). 
During normal ES cell culture, LIF is a strong supressor of mesodermal and 
endodermal differentiation (Smith, 1991). However, an appreciable proportion of 
GFP positive cells were obtained from UF-treated monolayers (around 50% 
compared to controls, around 35% of all cells), which may indicate that UF receptor 
signalling does not block the neural lineage very efficiently and/or that some factor 
present in serum normally collaborates with UF. 
The antagonist for the UF receptor hLIF-05 (Vernallis, 1997) (at a 
concentration determined to completely block the effect of 10 units/ml of UF) had 
little effect on the monolayer differentiation, suggesting that commitment during 
monolayer differentiation is not dependent on LIF signalling. 
5.4.2 BMP-4 
In fish and amphibian embryos, the naïve ectoderm becomes epidermal or 
neural depending on the presence of signals from the underlying mesoderm. Ventral 
mesoderm secretes BMP-4, a TGF3-like growth factor, which causes the unspecified 
ectoderm to assume an epidermal fate. Dorsal mesoderm secretes antagonists of 
BMP, neutralising the activity of BMP-4 produced by the ectoderm and by the 
ventral mesoderm. Naïve ectoderm that receives no BMP signal assumes a neural 
fate. This is the proposed "default" model for neural induction which proposes that 




















(Wilson and Hemmati-Brivanlou, 1995; Wilson and Hemmati-Brivanlou, 1997)(see 
section 1.2). 
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Figure 5.6 	Effect of LIF signalling on monolayer differentiation 
ES cells were plated at 2x10 5 cells per gelatinised 6cm plate in N2B27 in the 
presence of 100U/ml human recombinant LIF or the LIF receptor antagonist hLif05 
at a concentration to inhibit lOU/mI UF. Medium was changed every two days with 
fresh growth factors and inhibitors. At days 4 and 6 cells were dissociated and 
analysed by flow cytometry. The proportion of EGFP positive cells in each condition 
is plotted normalised against control cultures. Each bar represents two independent 
experiments performed in triplicate, and the controls averaged 72%. Bars: Standard 
deviation. 
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In vitro studies on several ES cell differentiation systems have established a 
negative role for BMP-4 in neural induction of these cells (Kawasaki et al., 2000; 
Rohwedel et a/., 1998; Tropepe et al., 2001; Wiles and Johansson, 1999). When 
added to the monolayer differentiation, 50ng/ml BMP-4 completely suppressed the 
emergence of Soxl-GFP positive cells (Figure 5.8). This happened while there was 
an increase in the cell numbers and alternate cell morphologies appeared (Figure 
5.7). However, no cells with overt neuronal morphology were generated, consistent 
with the notion that BMPs suppress neural differentiation of naïve ectodermal cells. 
This BMP-4 effect was also seen at lower concentrations (lOng/mI and 5ng/ml) (not 
shown). The cell morphologies of BMP-4 treated monocultures resembled those of 
rnesendodermal cells appearing in ES cell cultures upon withdrawal of LIF (Figure 
5.7). RT-PCR analysis has shown that mesodermal markers are upregulated in such 
cultures, indicating that BMP directs a non-neural differentiation pathway of ES cells 
under such conditions (M Li, unpublished). 
5.4.3 Noggin and Chordin 
These are BMP antagonists secreted by the organiser during gastrulation. In 
Xenopus embryos, treatment of animal caps with these factors causes 
differentiation to neural tissue. In a whole Xenopus embryo, Chordin and Noggin 
have dorsalising activities. Single targeted mutations in either of these genes in the 
mouse results in normal gastrulation and neural induction, with effects seen later 
during embryogenesis. The compound mutants however have a range of 
phenotypes, commonly lacking anterior neural structures, suggesting a redundancy 
in the action of the two molecules (Bachiller et al., 2000) in anterior nervous system 
induction. 
In an attempt to increase the proportion of GFP positive cells, Noggin or 
Chordin were added to the cultures. At the concentrations tested (0.1g/ml, Noggin 
also at 0.511g/ml), these factors consistently had no effect on the differentiation 
efficiency (Figure 5.8). 
To test if the concentrations of Noggin and Chordin used were effective, cells 
were plated in the presence of lOng/mI BMP-4 and 0.1p.g/ml Noggin or Chordin in 
N21327 medium. On days 4 and 6, cells were analysed by flow cytometry for Sox-
GFP fluorescence. Noggin completely relieved the negative effect of BMP-4, whereas 
Chordin did not (Figure 5.8). This effect can possibly be explained by the different 
affinities Noggin and Chordin have for BMP-4 (Piccolo et al., 1996; Zimmerman et 
al., 1996) or by increased stability of the recombinant Noggin/Fc chimera compared 
to Chordin. Moreover, the concentration of exogenous BMP-4 used (lOng/mt and 
50ng/ml) is probably much higher than the levels likely to be present in the 
cultures. 
Addition of Noggin and Chordin alone or in combination to ES cells plated at 
similar conditions to those used for monolayer differentiation but in the presence of 
serum was not sufficient to convert them to a Sox-1 positive phenotype (not shown). 
This suggests that serum contains other factors besides BMPs that inhibit neural 
differentiation. 
Figure 5.7 Differentiated cell morphology after BMP treatment 
Morphology of 46C culture treated with BMP-4 for 6 days during monolayer 
differentiation. Scale: 100.im. 
79 
Day 6 
Effect of BMP signalling on monolayer differentiation 
	






0 I i 
06 
04 
I 02 IlIUM, 
Uj 
Day 4 
Figure 5.8 Effect of BMP signalling on monolayer differentiation 
ES cells were plated at 2x10 5 cells per gelatinised 6cm plate in N2B27 in the 
presence of 50ng/ml BMP-4 and/or 0.1g/ml Noggin or Chordin. Medium was 
changed every two days with fresh growth factors. At days 4 and 6 cells were 
dissociated and analysed by flow cytometry. The proportion of EGFP positive cells in 
each condition is plotted normalised against control cultures. Each bar represents 
two independent experiments performed in triplicate, except for Noggin and BMP (5 
experiments in triplicate), and the controls averaged 57%. Bars: Standard deviation. 
5.4.4 FGF-2 
Recent experiments in the chick have suggested that neural induction in that 
organism is more complex than the default mechanism described for amphibians 
and fish (Streit et al., 2000). This theory has postulated that neural differentiation 
happens in four steps: Competence, specification, commitment and differentiation 
(Wilson and Hemmati-Brivanlou, 1997). Neural competence is acquired before the 
onset of gastrulation, when no BMPs or BMP antagonists are being expressed. 
Competent cells have the ability to become neural precursors if exposed to the right 
combination of signals. Specification occurs when cells receive the signals to 
become neural, but will still respond to signals that repress a neural character. 
When cells become committed, they will progress to become neuronal or glial even 
in the presence of signals that repress a neural character. Differentiation is the final 
stage in which cells exit the cell cycle and terminally differentiate. One factor that 
has been proposed to act at the competence stage and is therefore required for 
neural induction is signals from the FGF family. 
In an experiment trying to address whether the efficiency of neural 
differentiation can be enhanced by such FGF signals, 20ng/ml FGF-2 (with or 
without 5tg/ml heparin) was added to the cultures. The result was a slight 
suppression of neural differentiation as measured by GFP fluorescence (Figure 5.9) 
accompanied by an apparent increased growth of the culture (not shown). 
5.4.5 SU5402 
Experiments in the chick done to investigate the role of FGF signalling in 
neural induction revealed that blocking FGF receptor signalling causes medial 
epiblast cells (which would normally give rise to neural tissue) to become epidermal. 
This is in agreement with a proposed role of FGFs in promoting competence of the 
ectoderm to respond to neuralising signals. These experiments were done using a 
pharmacological inhibitor of the FGF receptor family. This compound, SU5402, 
occupies an ATP binding site on the kinase domain of the receptor molecule and 
blocks activation of downstream pathways (Mohammadi etal., 1997). 
Addition of SU5402 to monolayer differentiation at 5jtM causes a sharp 
reduction in the proportion of GFP positive cells (Figure 5.9) with no overt effect on 
the viability or proliferation (although the proliferation rate was not measured). This 
result is already apparent at day 3 of monolayer differentiation, suggesting that the 
action of SU5402 is at the level of neural specification rather than survival or 
expansion of neural precursors. Lower concentration of the compound (2pM), 
reported to inhibit neural induction in chick epiblast explants (Wilson et al., 2001) 
has no effect on the differentiation efficiency (Figure 5.9), whereas a high dose 
(20jM) killed the cultures (not shown). Furthermore, co-addition of Noggin (Figure 
5.9) or Chordin (not shown) with 5M SU5402 did not rescue the effect of SU5402. 
The specificity of the effect of SU5402 on FGF signalling was verified from 
experiments using a dominant negative FGF receptor in this system which gave 
similar results to those obtained with SU5402 (Ying etal., submitted). 
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Figure 5.9 Effect of FGF signalling on monolayer differentiation 
ES cells were plated at 2x10 5 cells per gelatinised 6cm plate in N2B27 in the 
presence of 20ng/ml FGF-2, 2iM or 5M SU5402. Medium was changed every two 
days with fresh growth factors. At days 4 and 6 cells were dissociated and analysed 
by flow cytometry. The proportion of EGFP positive cells in each condition is plotted 
normalised against control cultures. Each bar represents two independent 
experiments performed in triplicate, except for 2.tM SU5402 (4 experiments in 
triplicate) and 5M SU5402 (5 experiments in triplicate), and the controls averaged 





















5.5 Soxi positive cells are free from ES cells 
To verify that Soxl-GFP cells are free from ES cells, 46C ES cells were 
allowed to differentiate in monolayer for 4 days, then were dissociated by mild 
trypsin treatment and resuspended in PBS containing 10%  FCS. The cells were then 
passed through a 35pm mesh filter to remove cell clumps and analysed by flow 
cytometry for green fluorescence (Figure 5.10a). Appropriate gates were set to 
cleanly separate GFP positive (58.5%) from GFP negative (17.5%) cells, and then 
cells were sorted into two tubes according to their GFP fluorescence. RNA was 
extracted from these populations and after reverse transcription, PCR was 
performed using specific primers for Soxi, egfp, Oct-4 and /3-actin. 
As anticipated, egfp mRNA was expressed strongly in the GFP positive 
population, along with Soxi, whereas they were only expressed at a very low level 
by the GFP negative population (Figure 5.10b). The expression of Soxi by the GFP 
negative population is probably reflecting the onset of expression of egfp when not 
enough protein is present in the cytoplasm to confer green fluorescence to the cell. 
Importantly, the GFP positive fraction did not express the essential ES cell 
transcription factor Oct-4, in contrast to the negative population, in which the Oct-4 
mRNA was abundant. 
This indicates that the Soxi positive cells are free from contaminating ES 
cells. Sorting positive from negative populations at this timepoint (day 4) results in 
poor viability of the Soxi positive fraction. However, when sorted into ES cell 
medium supplemented with LIF, GFP negative cells gave a high number of ES cell-
like colonies that stained positive with an antibody against Oct-4. Few ES cell 
colonies were observed in the sorted cultures of GFP positive cells, and 
contamination of the sort can probably account for this. 
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Figure 5.10 Soxi positive cells are free from ES cells 
(a): FACS profile of the differentiating culture at day 4. Dead cells and cellular 
debris were excluded from the analysis based on their light scatter characteristics. 
Gates separating the positive (Ri; 58.5%) from the negative (R2; 17.5%) 
population are shown.(b): RT-PCR analysis of sorted positive (+) and negative (-) 
cells from (a) and ES cells growing in standard ES cell medium (ES) Cells with 
intermediate levels of GFP fluorescence probably represent the tails of the 
distribution curves for the positive and negative populations, although some 
intermediate cell type with low Soxi expression cannot be excluded. 
5.6 Discussion 
Monolayer differentiation is a novel differentiation protocol for neural cell 
generation from ES cells. The main advantages over other ES cell differentiation 
systems are: completely defined media, no aggregation or co-culture of the cells, 
and high efficiency. Neural differentiation of ES cells in completely defined culture 
medium has been described in the past (Tropepe et al., 2001; Wiles and Johansson, 
1999), but the frequency of neural determination is very low and the differentiation 
is happening in cell aggregates. An efficient method for generation of neural cells 
from ES cells in defined culture media without aggregation has also been described, 
but this depends on the co-culture of ES cells with stromal cells (Kawasaki et al., 
2000). The nature of these interactions is still unclear, so hindering the study of 
lineage commitment requirements. Moreover, in light of recent observations 
suggesting that ES cells spontaneously fuse to other cells when co-cultured, such 
mixed cultures become less attractive to study cell lineage specification (Terada et 
al., 2002; Ying et at., 2002). A further advantage of monolayer differentiation over 
previously described protocols for ES cell differentiation is that nutrients and other 
media factors are equally available to all the cells in the culture, making the cultures 
much more homogeneous. 
During the course of monolayer differentiation, ES cells efficiently convert to 
neural cells expressing Soxi. The conversion happens asynchronously through the 
cultures, suggesting a stochastic mechanism for neural determination. Expression of 
Soxl-egfp starts in small clusters of cells and is very rarely seen in isolated cells. 
This indicates that signalling between cells in a colony may be an important factor in 
the differentiation process. However, the efficiency of the differentiation is sensitive 
to variation in cell number; high plating density results in better plating efficiency, 
but the proportion of Soxl-egfp positive cells generated is lower. Low plating 
density compromises the initial survival of the cells, presumably due to lack of 
autocrine trophic signals and the absence of serum. The surviving cells are however 
more efficiently converted to Soxi positive neural precursors, a fact which indicates 
that some factor(s) produced by the ES cells (e.g. LIF) negatively regulate neural 
differentiation and promote survival and ES cell maintenance. The presence of 
background cell types in monolayer culture as seen in figure 5.4 is not believed to 
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be the cause of the differentiation due to production of some factor, as their 
number varies between experiments and their presence does not correlate with an 
increased differentiation efficiency. Indeed, in several experiments no background 
differentiation was observed, and the efficiency of differentiation was high (above 
65%), indicating a negative effect of such cells on the efficiency of the 
differentiation. 
The emergence of Soxl-egfp positive cells is progressive in differentiating 
cultures. At day 2, only a few colonies contain Soxi positive cells, but a day later 
both the number of positive cells in the colonies and the number of positive colonies 
increase, contributing to an overall increase in the proportion of Soxi positive cells. 
The next three days (days 4, 5 and 6) the proportion of Soxi positive cells reaches 
its maximum; this is accomplished by the acquisition of Soxi expression of yet more 
colonies and a proliferation of Soxi expressing cells while maintaining Soxi 
expression. Importantly, not all cells in culture express Soxi at any stage, indicating 
the acquisition of alternative non-neural fates under the same conditions as well as 
persistence of ES cells. 
Since no exogenous mitogen is present in the culture medium, cells start to 
differentiate according to their intrinsic programme. After day 4 neurons start 
appearing in the cultures. Neurons are Soxi negative as they are non-proliferative 
and Soxi is confined to mitotic cells (Pevny et al., 1998). As the numbers of 
neurons increase and Soxi positive cells start differentiating and turning off Soxi, 
the proportion of egfp positive cells starts to decline after day 6. By day 10 after the 
start of the differentiation, the proportion of cells still expressing egfp is less than 
50%. At later timepoints the number of neurons continues to rise and the 
proportion of Soxi positive precursors to decline. 
The number of cells present in the cultures was counted to discount the 
possibility that this protocol depends on the amplification of rare cells present in the 
initial ES cell cultures. A previous publication reporting ES cell differentiation in 
serum-free medium reported a dramatic reduction in cell number after initial plating 
(Tropepe et al., 2001). That report was based on observations made on <0.2% of 
the initially plated cells; it is therefore conceivable that those cells were already 
committed to a neural fate, having spontaneously differentiated in the starting ES 
cell culture. In our system, the total number of cells increases exponentially, 
indicating that ES cell lineage commitment in serum free conditions is a general 
property of ES cells rather than that of a rare subpopulation. 
When the components of the medium were dissected to identify the neural 
inducing factor(s), it was discovered that several of the protein components of the 
N21327 medium are not necessary for the differentiation. Transferrin is necessary for 
cell viability and insulin assists with cell attachment, but can be omitted. These 
results resembled the default model for neural induction first proposed for 
amphibians (Weinstein and Henimati-Brivanlou, 1997). There have been some 
reports indicating that ES cells adopt neural fate in a default-like fashion (Tropepe 
et al., 2001; Wiles and Johansson, 1999), however the differentiation involved 
formation of cell aggregates, precluding systematic analysis of the lineage restriction 
process and the signals that govern it. 
To address this hypothesis, proteins thought to be important for neural 
induction were added or inhibited during the course of monolayer differentiation. 
BMP-4 caused a strong suppression of the emergence of Soxi positive cells, 
consistent with its role as an inhibitor of neural fate during gastrulation stages in 
vivo. In frog and chick experiments, BMPs are thought to promote epidermal over 
neural fate of naïve ectodermal cells. Interestingly, preliminary evidence suggests a 
mesodermal rather than epidermal differentiation upon BMP treatment during this 
differentiation. 
ES cells express Bmp4 as well as BMP receptors (Roelen et al., 1997), so I 
hypothesised that endogenous BMP signalling might be limiting the efficiency of 
differentiation. However, addition of Noggin or Chordin to the medium at the time 
of plating did not significantly alter the proportion of Soxl-egfp cells generated. This 
could be because ES cells express high levels of another inhibitor of BMP signalling, 
Follistatin (QiLong Ying, unpublished). This result indicates that autocrine BMP 
signalling is not a limiting factor for neural specification during monolayer 
differentiation. Addition of Noggin and Chordin either alone or in combination to 46C 
ES cells growing in serum containing medium without UF did not result in the 
generation of Soxl-egfp positive cells. This result suggests that the apparent default 
differentiation of ES cells to neural cells is inhibited in the presence of serum by 
mesoderm-inducing factors other than BMPs. 
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Addition of LIF to the cells causes a reduction in the proportion of egfp 
positive cells of rv50% compared to the untreated control cultures (Figure 5.6). This 
is in stark contrast to a previous report (Tropepe et al., 2001) that direct fate 
specification of ES cells in serum-free conditions proceeds via a LIF-dependent 
primitive neural stem cell. This is hardly surprising for a number of reasons: Firstly, 
LW receptor (LIFR) deficient embryos, in which all LIF signalling is abolished, show 
no defect in early neural development (Li et al., 1995). Secondly, LIF has an 
established role as a self-renewal factor for ES cells, acting via the activation of the 
transcription factor STAT3 (Matsuda et al., 1999; Niwa et al., 1998; Smith et al., 
1988; Williams et al., 1988). Moreover, in the experiments described by Tropepe et 
a!, the majority of ES cells die in the first few hours after plating, suggesting that 
the effect of LIF is to enhance the viability of the ES cells rather than to promote 
the survival of a primitive neural stem cell. Other experiments have previously 
indicated that UF suppresses ES cell differentiation in serum free conditions very 
similar to those reported by Tropepe et al. (Wiles and Johansson, 1999). The slight 
suppression of differentiation in the presence of LW may be due to ES cell self 
renewal rather than alternative differentiation, as judged by morphology of cells in 
the cultures. 
In the presence of serum, LIF is essential for ES cell maintenance. 
Withdrawal of LIF from ES cell cultures growing in the absence of feeders in 
conventional serum-containing medium causes rapid differentiation into mesoderm 
and endoderm (Smith, 1991). Therefore, routine culture of ES cells can be 
considered as a suppression of mesodermal and endodermal differentiation by LIF. 
The result discussed above, that ES cell differentiation in monolayer is only 
moderately inhibited by UF indicates that this factor is not a potent inhibitor of 
neural differentiation. This implies that maintenance of ES cells by UF requires the 
presence of a mesoderm/endoderm inducing signal and/or an independent activity 
to complement UF. 
I wanted to determine whether autocrine LIF signalling is a limiting factor for 
monolayer differentiation. Inhibition of UF signalling by the LIF antagonist hUF-05 
did not increase the efficiency of Soxi positive cell generation. The fact that the 
proportion of GFP positive cells decreased in the presence of hUF-05 could be due 
to reduced viability of ES cells in the absence of autocrine LIF signalling in the first 
few hours after plating in serum free medium. 
Addition of exogenous FGF resulted in a slight reduction in the proportion of 
egfp positive cells (Figure 5.9). This contrasts with the previous report by Tropepe 
et a!, which reports an increase in the number of neural colonies generated upon 
addition of FGF. However, as discussed previously, in the system used for their 
experiments, viability is compromised, so the effect of FGF might be to promote 
viability rather than neural specification. ES cells normally produce FGF-4 (Yuan et 
al., 1995). In our protocol, viability is high and the FGF needed for ES cell 
differentiation could be provided in an autocrine/paracrine fashion. 
This is supported by the fact that FGF inhibition potently suppresses neural 
fate. This indicates that endogenous FGF signals are important either for the 
production of intermediate cells or the conversion of competent cells to Soxi 
positive ones. Tropepe et al. also report that inhibition of FGF signalling, either by 
blocking antibodies or using FGF receptor -I- cells, reduces the efficiency of the 
differentiation. These observations however are made on a very small proportion of 
initially plated cells and have little bearing on lineage specification. The reduction of 
efficiency observed in our system upon addition of high concentration of FGF could 
be because it stimulates proliferation of non-neural cells or because it is inducing 
mesoderm formation. 
Inhibition of FGF signalling by the inhibitor SU5402 significantly reduced the 
appearance of Sox1 expressing cells. This result indicates that endogenous FGF 
signals are important for neural specification of ES cells. A previously proposed 
action of FGFs in neural induction postulates a dual function: promotion of neural 
fate via an unknown mechanism and repression of Bmp gene expression. Co-
addition of Noggin or Chordin to the SU5402 treated monolayers did not restore the 
efficiency of neural specification, indicating that the requirement for FGFs is not 
solely to repress Bmp5. This is consistent with experiments in the chick where 
strong inhibition of FGF signalling causes a repression of neural induction which 
cannot be reversed by BMP inhibition. However, in the same experiments, a lower 
dose of FGF inhibitor caused a Noggin-reversible repression of neural fates. My 





The aim of the project was to create a reporter cell line to study neural 
differentiation of ES cells. The gene selected for the insertion of the reporter was 
Soxi because of its restricted expression during development and the fact that it is 
not expressed by ES cells. The targeting experiment resulted in the replacement of 
all of the Soxi open reading frame by the dual reporter/selection cassette EGFP 
IRES pac. Selection of transfected ES cells was achieved by virtue of a CMV hyTK 
cassette flanked by lox511 sites. After identification of correctly targeted clones by 
Southern hybridisation, selected clones were subjected to differentiation and 
analysed by flow cytometry for green fluorescence. No fluorescent cells were visible 
at that stage. The clones were subsequently transiently transfected with a Cre 
expressing plasmid to remove the CMV hyTK cassette. Recombined subclones were 
selected in the presence of ganciclovir and screened by Southern blotting. One 
clone was obtained initially and further examined, although three others were 
subsequently isolated and exhibited similar expression. This clone (46C) upon 
embryoid body neural differentiation upregulated the Soxl-GFP reporter and EGFP 
positive cells emerged. 
The reason for the lack of fluorescence upon in vitro differentiation before 
the excision of the selection cassette remains unknown, but this phenomenon has 
been documented before (Faust et at., 2000). A possible explanation is that the 
presence of a strong promoter (such as the CMV promoter) recruits transcriptional 
machinery from a nearby weaker promoter (Soxi) resulting in lower levels of 
expression from that promoter. Another possible explanation is that the presence of 
the CMV hyTK cassette 3' to the Soxi ORF acts as a spacer separating regulatory 
sequences present in the 3' region of Soxi from the promoter. This could result in 
reduced efficiency of the promoter. 
The previous report on Soxi targeting also describes lack of the reporter 
gene activity after insertion into the Soxi ORF (Nishiguchi et al., 1998). The authors 
hypothesise that this is due to the fact that "translation does not initiate from the 
translation start of 3geo" (the reporter was fused to the first 56 amino acids of 
Soxi). An alternative explanation suggested by my data is that the presence of the 
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MCi neo cassette 3' of the reporter (used for selection in ES cells) competing with 
the endogenous promoter for transcriptional machinery, or the presence of the MCi 
neo sequences separating promoter from regulatory/enhancer sequences is the 
reason. 
Germline transmission of the targeted allele was accomplished only after the 
deletion of the selection cassette. Despite extensive breeding of chimeras generated 
from the original ES cell clones before the Cre-mediated removal of the CMV hyTK 
cassette, no germllne transmission was observed. It is known that male transgenic 
animals carrying the TK gene rarely transmit it to their offspring. This is because a 
cryptic promoter sequence within the TK gene causes ectopic expression of a 
truncated product in mouse testis which in turn causes reduced fertility of the sperm 
(Ellison et al., 2000). The results obtained here indicate that the property of the TK 
gene to cause reduced fertility is maintained in its fusion with the hph gene 
encoding for hygromycin phosphotransferase. 
The targeting efficiencies with the two vectors described in chapter 3 were 
very similar (2-3%). This was expected, as the homology arms used for their 
construction and the ES selection marker were identical. The main parameters that 
influence the targeting frequency are the length of the homology arms and the use 
of isogenic DNA, i.e. DNA derived from the same strain of mouse as the cells to be 
targeted. In both targeting experiments, the same cell line was targeted with 
identical regions of homology derived from isogenic DNA. Unfortunately no direct 
comparison can be drawn between this and a previous report on Soxi targeting 
(Nishiguchi et al., 1998) because the frequency of targeting for those experiments is 
not clearly stated. These authors describe that 3 correctly targeted clones were 
injected into blastocysts and passed trough the germline, out of 465 screened. This 
implies that the targeting frequency was at least 0.65% if the only correctly 
targeted clones were those three. The total homology was smaller in those 
experiments, especially at the 3' of the ORF, which approached the 1Kb shown to be 
a minimum requirement for efficient recombination. 
Heterozygous animals were generated on an outbred background and 
appeared phenotypically normal. Homozygous null animals for Soxi on the same 
background were obtained, but pups appeared smaller than their littermates. They 
also had smaller eyes with opaque lenses and appeared to be trembling. Adult -I- 
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animals had a more curved stature compared to their littermates, as well as smaller 
eyes and opaque lenses. Such homozygous null animals also suffered from sporadic 
fits, which caused them to roll over repeatedly for several minutes. The previously 
reported knockout for Soxi has the same phenotype on both inbred (129) and 
outbred (MF1) background. The cause of the epileptic fits has not been described in 
detail, but it appears they originate from the olfactory tubercle, which is missing 
from the Soxi null animals (V. Episkopou, personal communication). 
6.2Soxl-GFP expression during development 
Expression of the reporter construct was followed during mouse 
development and found to correlate well with previously published accounts. The 
onset of GFP fluorescence was found to be later than the onset of Soxl expression 
determined by RNA hybridisation or immunofluorescence. This can be explained by 
two facts: Firstly, EGFP is a protein that needs to be correctly folded in order to 
fluoresce, and correct folding of it may take a few hours. Secondly, the 
concentration of EGFP molecules in the cytoplasm needed to confer fluorescence is 
limiting. Both in situ hybridisation and immunofluorescence employ the use of an 
antibody to detect the primary signal. This step can amplify the intensity of a weak 
signal, as in the case of low mRNA or protein levels. EGFP fluorescence is not 
amplified, so low levels of expression may pass undetected. 
Soxl expression has previously been documented to be associated with 
proliferating cells of the CNS (Pevny et al., 1998). This was not directly tested in my 
experiments, but the sites where Sox-egfp fluorescence was observed were areas of 
proliferation. In the early neural tube the majority of cells are dividing precursors 
with the exception of roofplate and floorplate cells which exit the cell cycle and 
participate in patterning the precursor cells of the neural tube along the dorso-
ventral axis. As the neural tube thickens with continuing division of progenitor cells, 
cells start to differentiate and migrate outwards to populate the outer layers of the 
neural tube initially with neurons and later with glia. Fluorescence at these later 
stages becomes confined to the cells around the ventricular surface of the neural 
tube, which continue to proliferate. In the developing and adult brain expression is 
seen in regions known to contain proliferative cells, such as the telencephalic 
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vesicle, the subventricular zone of the lateral ventricles and the rostral migratory 
stream of migrating neuroblasts. 
6.3 Monolayer differentiation and the default model 
Monolayer differentiation resembles the default model for neural induction. 
Multipotent ES cells, resembling in their pluripotency primitive ectoderm cells of the 
mouse blastocyst, convert efficiently in the absence of any exogenous stimuli to 
neuroectodermal cells. This lineage restriction is blocked by bone morphogenetic 
protein, as is the neural differentiation of frog naïve ectoderm. ES cells express both 
BMP5 and BMP receptor RNAs, but the level of endogenous BMP signalling does not 
appear to inhibit their differentiation under monolayer differentiation conditions. 
Addition of exogenous BMP antagonist did not enhance the differentiation efficiency, 
but could completely reverse the repression caused by exogenous BMP. 
A difference between the effect of BMP during monolayer differentiation and 
during neural induction in frog is that in the ES cell system BMP5 seem to promote 
mesodermal fates. Frog animal ectoderm cells acquire an epidermal fate if BMP 
signals are present, and a neural fate upon BMP inhibition. In the frog animal cap 
assay, whole explants cannot acquire neural fate without antagonism of 
endogenous BMP activity, but dissociation is sufficient to dilute out these signals 
and allow neural determination (Grunz and Tacke, 1989). This apparent discrepancy 
can be explained by different level of BMPs or their receptors being expressed in 
mouse ES cells to frog animal caps, or by the fact that ES cells express high levels 
of the BMP antagonist Follistatin and lower levels of the BMP antagonist Noggin 
(QiLong Ving, unpublished). Activity of these endogenous antagonists may be 
enough to counteract the effect of endogenous BMP5 in these relatively low density 
cultures. 
Analysis of the effect of other factors implicated in neural determination 
established a requirement for FGF signalling during monolayer differentiation. 
Pharmacological inhibition of signalling through FGFR caused a sharp reduction in 
the proportion of neural cells generated. This finding is in agreement with a 
proposed role of FGFs in neural determination (Wilson and Edlund, 2001). However, 
addition of exogenous FGF2 did not increase the proportion of Soxl-EGFP cells 
generated. This effect may be explained by the fact that ES cells express high levels 
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of FGF4. It is possible that autocrine FGF4 is sufficient to convert ES cells to neural 
cells, and exogenous FGFs only enhance proliferation of both neural and non-neural 
cells generated in the cultures, without skewing their relative proportions. 
It has been proposed that the action of FGFs in neural induction is double: 
low levels of FGF signals act via an unknown pathway to promote neural fate, while 
high levels repress transcription of Bmp, indirectly promoting neural over non-neural 
fate. At a level determined to be sufficient to repress neural differentiation, the 
effect of FGF inhibition cannot be reversed by co-addition of Noggin, suggesting 
that the function of FGF is not simply to repress endogenous BMP levels. Such an 
action cannot be excluded however on these results, due to the expression of BMP 
antagonists by ES cells mentioned above. Furthermore, members of the FGF family 
are being expressed before and during mouse gastrulation and neural induction 
(Hebert etal., 1991; Niswander and Martin, 1992), so a role for FGFs in mammalian 
neural induction cannot be precluded without further studies. 
An interesting feature of monolayer differentiation is the time required for 
conversion of ES cells to neural precursors. 4 days after initiation of the 
differentiation, the vast majority of 46C cells express EGFP, indicating a conversion 
to the neural lineage. In vivo, ES cells are thought to correspond to the post 
implantation epiblast, around 4 days of development. The neural plate stage is 
around E7.5, and Soxi expression as judged by EGFP expression in the animals 
generated from the 46C cells starts at E8.5. Therefore, the timing of neural 
determination of ES cells during monolayer differentiation is very similar to the 
timing of generation of Soxl positive cells in the neural plate from the post-
implantation epiblast. This timing similarity is seen in frog animal cap explants. 
Animal cap explants are derived from stage 10+ (around lOh post fertilisation) 
Xenopus embryos. When dissociated for more than 5 hours, they convert to neural 
cells equivalent to stage 14 (around 16h post fertilisation). This common aspect of 
the two in vitro differentiation systems may be an indication of a conserved 
temporal programme during these stages of development, controlling certain 
differentiation events. 
The facts that the initiation of neural determination during monolayer 
differentiation is asynchronous between colonies, and that none of the factors 
tested could consistently increase the proportion of neural cells above that of 
control untreated cultures prompt some questions. Is the process of neural 
determination stochastic, or governed by some community effect? Is the cell 
microenvironment providing a cue for neural determination to start, and what could 
the nature of that cue be? Is there an unknown factor produced by the cells at a 
limiting concentration required for neural determination? To address these points, 
more experiments need to be done with addition of factors during shorter periods of 
the differentiation process, dissociation of differentiating colonies before the onset 
of Soxi expression and timelapse observation of the differentiation process. 
6.4Summary 
This work has succeeded in generating, using gene targeting, a Soxi reporter 
cell line (46C). The allele generated is null and homozygous animals generated have 
a phenotype indistinguishable from the previously reported phenotype for Soxi null 
animals. Expression of the egfp reporter during development closely follows the 
expression of the Soxi gene and can be used to visualise proliferating precursors. 
The 46C cell line was used to analyse the conditions necessary for neural 
determination of ES cells in defined culture medium and on adherent monoculture. 
The results indicate that ES cells enter the neural fate upon liberation from self-
renewal signals efficiently, and that this transition is dependent on endogenous FGF 
signals. Although BMP signals potently suppress this neural determination, inhibition 
of BMP either by antagonists or at the transcriptional level by FGFs does not appear 
to be required for it, contrary to the default model for neural induction. The mode of 
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